Sign Up
You are not currently logged in. Please log in to CEUfast to enable the course progress and auto resume features.

Course Library

LPN IV Series: Central Venous Catheters and Arterial Catheters

5 Contact Hours
CEUfast OwlGet one year unlimited nursing CEUs $39Sign up now
This peer reviewed course is applicable for the following professions:
Licensed Practical Nurse (LPN), Licensed Vocational Nurses (LVN)
This course will be updated or discontinued on or before Sunday, June 8, 2025

Nationally Accredited

CEUFast, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. ANCC Provider number #P0274.


This course does not meet the Florida LPN IV Certification requirement.
Outcomes

≥ 92% of participants will know how to care for a central or arterial line properly.

Objectives

This module will cover fundamental issues of a central line IV catheter and arterial line nursing care, like observing for and preventing complications.

After completion of this module, the participant will be able to:

  1. Characterize indications for the use of a central venous line.
  2. Identify medications that are vesicants.
  3. Summarize pre-insertion and post-insertion complications of central venous lines.
  4. Describe indications for using an arterial catheter.
  5. Outline complications associated with arterial catheters.
  6. Specify aspects of nursing care for a patient with a central venous or arterial line. 
CEUFast Inc. and the course planners for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Last Updated:
  • $39 Unlimited Access for 1 Year
    (Includes all state required Nursing CEs)
  • No Tests Required
    (Accepted by most states & professions)
  • Instant Reporting to CE Broker
  • Instant Access to certificates of completion
Logo Audio
Now includes
Audio Courses!
Learn More
To earn a certificate of completion you have one of two options:
  1. Take test and pass with a score of at least 80%
  2. Attest that you have read and learned all the course materials.
    (NOTE: Some approval agencies and organizations require you to take a test and "No Test" is NOT an option.)
Authors:    Dana Bartlett (RN, BSN, MA, MA, CSPI) , Desiree Reinken (MSN, APRN, NP-C)

Introduction

Central venous lines and arterial catheters are commonly used in healthcare. They are often essential in critically and chronically ill patients; however, they can be used for acute situations. Compared with peripheral IV lines, the clinical indications for their use are more complex and, often, more serious. There are more complications, often more severe, associated with these devices, and the daily care of a patient with a central line or an arterial catheter is more involved.

Central Lines

Definitions

A central venous line, also known as a central venous catheter or a central venous access device (CVAD), is an intravenous (IV) catheter that has been inserted and positioned so the catheter tip is in the proximal one-third of the superior vena cave, the right atrium, or the inferior vena cava of the heart (Lockwood & Desai, 2019). Essentially, it is an indwelling device inserted into a larger and more central vein.

Central venous catheters are commonly used medical devices. It has been estimated that in intensive care units (ICUs) in the United States (US) alone, there are 15 million days when a central venous catheter has been used, or the patient has had a central venous catheter in place (McConville & Patel, 2015). In the US, 5 million central line catheters are inserted annually (Sakuraya et al., 2022).

Central venous catheters are usually placed in the internal jugular, femoral, or subclavian veins; these are the preferred sites for temporary placement (Berry, 2022). More information on each site will be discussed later in this course.

Indications for Use

There are many indications for using a central venous catheter; many are patient and situation-specific. The more common indications for the use of a CVAD are listed in Table 1.

Table 1: CVAD Indications
Administration of irritants or vesicants
Administering vasopressors
Inability to obtain peripheral IV access
Invasive hemodynamic monitoring
Long-term venous access
Rapid administration of IV fluids
Renal replacement therapy
Total parenteral nutrition
Transvenous pacemaker placement
(Manrique-Rodríguez et al., 2021; McConville & Patel, 2015)

Administration of Irritants/Vesicants

Many drugs are not able to be infused through a peripheral line. The pH and osmolarity (the concentration of a solution) of some drugs and the vasoconstricting effect of other drugs make them unsuitable for administration through a peripheral IV line. These types of drugs are classified as vesicants. They are very irritating and potentially damaging to small veins, and infiltration of these medications may cause extravasation. Formally, a vesicant is defined as an agent that is capable of causing tissue damage when it escapes from the intended vascular pathway into surrounding tissue (Gorski et al., 2021).

Many drugs can be considered vesicants and include the following.

Antiemetics:

  • Hydroxyzine
  • Promethazine

Cardiovascular agents/diuretics:

  • Chlorothiazide
  • Digoxin
  • Dopamine
  • Epinephrine
  • Esmolol
  • Mannitol >5%
  • Phenylephrine
  • Norepinephrine
  • Tromethamine
  • Vasopressin

Electrolytes and nutritional supplementations:

  • Amino acid solutions ≥4.25%
  • Arginine
  • Calcium chloride
  • Calcium gluconate 10%
  • Dextrose >10%
  • Sodium bicarbonate ≥8.4%
  • Sodium chloride ≥3%
  • Parenteral nutrition

Some chemotherapeutic agents are well-known vesicants and include the following:

  • Actinomycin-D
  • Dactinomycin
  • Daunorubicin
  • Doxorubicin
  • Idarubicin
  • Mechlorethamine
  • Mitomycin-C
  • Paclitaxel
  • Vinblastine
  • Vincristine
  • Vinorelbine

Although this list is not all-inclusive, it does identify common vesicants.

Infiltration occurs when an IV catheter is dislodged from a vein, and IV fluid or medications infuse into the tissue.Extravasation is the infiltration of a vesicant and can cause irritation, pain, tissue necrosis, compartment syndrome, or even result in amputation (Brock & Cruz-Carreras, 2020; Chinn & Colella, 2017; David et al., 2020; Gorski et al.,2021; Masood et al., 2022).

Administering Vasopressors

Vasopressors are a type of drug, an adrenergic receptor agonist to be exact, that increases blood pressure, in part, by vasoconstriction. They essentially constrict or narrow blood vessels to increase high blood pressure. Vasopressors like dopamine, epinephrine, norepinephrine, and phenylephrine are primarily used to treat hypotension.

Vasopressors can cause extravasation, and although these drugs can and have been safely administered through peripheral IVs, it is recommended that, when possible, vasopressors should be given through a CVAD (Alexander, 2020; Gorski et al., 2021; Lewis et al., 2019; Shrestha et al., 2020; Tian et al., 2020).

Inability to Obtain Peripheral IV Access

Sometimes, obtaining IV access can be very challenging. At times, veins are just not visible or palpable, or if they are visible and palpable, they are in difficult places such as the wrist. Repeated attempts increase suffering and pain. Other times, patients are in an emergent situation and critical condition and need good access (Armenteros-Yeguas et al., 2017).

Invasive Hemodynamic Monitoring

A CVAD, positioned so the catheter tip is in the superior vena cava near the right atrium, can be used to measure central venous pressure or CVP (Parenti et al., 2022; Shah & Louis, 2022).

CVP measures the pressure in the vena cava, providing a good approximation of mean right atrial pressure and an estimate of ventricular preload (De Backer & Vincent, 2018; Parenti et al., 2022; Shah & Louis, 2022). Normal CVP is 8 to 12 mm Hg.

CVP monitoring is used to measure a patient's response to fluid resuscitation and determine a patient's volume status (De Backer & Vincent, 2018; Hill & Smith, 2021; Mercolini et al., 2021; Rhodes et al., 2017; Tolson, 2022).

CVP monitoring with a CVAD is invasive and time-consuming, and insertion and maintenance of a CVAD can cause serious complications (Parenti et al., 2022). In addition, some providers feel that CVP does not accurately predict response to fluid resuscitation and/or a patient's volume status and that it cannot and should not be used to guide treatment. Mercolini et al. (2021) wrote: "It is well known that CVP does not predict blood volume or fluid responsiveness." Other researchers have found that CVP measurement has many limitations that restrict its usefulness. Still, it is wiser to understand and consider these limitations rather than discard CVP monitoring completely. Clinicians and providers can decide if, how, and when to use CVP monitoring (Hill & Smith, 2021; Mercolini et al., 2021; Rhodes et al., 2017; Tolson, 2022).

Long-Term Venous Access

Central IV catheters are recommended when long-term venous access is needed, but an exact duration of time that defines long-term has not been established. In many cases, long-term is associated with the medical condition for which CVAD access is needed, e.g., cystic fibrosis and chemotherapy (Gorski et al., 2021). Authoritative sources have defined the long-term use of a CVAD as > 14-15 days (Gorski et al., 2021; Woller et al., 2016).

Rapid Administration of IV Fluids

A CVAD allows for the rapid administration of a large volume of IV fluid because it is inserted into a larger blood vessel than a peripheral IV (Somand and Ward, 2020). A CVAD may have multiple lumens.

Renal Replacement Therapy

Hemodialysis-central venous catheter insertion is commonly performed for patients with end-stage kidney disease. Hemodialysis uses a dialysis machine and a dialyzer to clean the blood. A hemodialysis-central venous catheter is used because it has a larger lumen, allowing for increased flow (Sohail et al., 2021). Though it is a standard procedure, many complications and adverse effects arise from the placement and procedure of a hemodialysis-central venous catheter.

Total Parenteral Nutrition

Total parenteral nutrition (TPN) is often needed for patients who are malnourished; it often takes an extended length of time for renourishment. TPN solutions are hyperosmolar and should be administered through a CVAD (Alexander, 2020; David et al., 2020; Gorski et al., 2021). Peripheral parenteral nutrition solutions, which are less concentrated and have a relatively lower osmolarity, can be given through a peripheral IV (Berlana, 2022).

Transvenous Pacemaker

A temporary transvenous pacing wire can be inserted through a CVAD (Lockwood & Desai, 2019). The pacemaker ensures the heart beats regularly, not too slow or fast. It is temporary, unlike implanted pacemakers in the chest (Tjong et al., 2019).

CVADs: A Review of the Different Types

Now that indications for CVADs have been discussed, it is time to review the types of different lines.

Peripherally Inserted Central Catheter (PICC)

A PICC is an IV catheter inserted into a peripheral vein. The catheter tip is positioned at the junction of the vena cava and the right atrium. A PICC is typically inserted into a vein in the upper arm, such as in the basilic, brachial, or cephalic vein. If necessary, the femoral vein can be used. Using ultrasound for inserting a PICC may reduce its failure due to an increased ratio of the catheter within the vessel (Berry, 2022; Gorski et al., 2021; Naik et al., 2022; Swaminathan et al., 2022; Yuen et al., 2022).

PICCs have several advantages: They can be inserted at the bedside, and compared to the other CVAD insertion sites, there are fewer insertion complications. They facilitate the transition of care, they are suitable for long-term (> 15 days) access, and they can be inserted by a vascular access nurse (Chopra et al., 2022; Gorski et al., 2021; Santos et al., 2020; Woller et al., 2016).

Indications for the use of a PICC are listed in Table 3. These indications are called the Michigan Appropriateness Guide for Intravenous Catheters (MAGIC). These recommendations align with other sources (Duwadi et al., 2018; Fohlen et al., 2022; Gorski et al., 2021; Woller et al., 2016).

Table 3: PICC – MAGIC Indications for the use of a PICC
Administration of irritants or vesicants
Delivering peripherally compatible solutions when the duration of therapy is ≥ 6 days
Delivering peripherally compatible solutions for patients in skilled nursing facilities (SNFs) when the duration of treatment is ≥ 15 days or when the patient will be moving from a hospital to an SNF
elivery of cyclical or episodic chemotherapy that can be administered through a peripheral vein in patients with active cancer, provided the proposed duration of such treatment is three or more months
Hemodynamic monitoring in a critically ill patient when monitoring will be needed for ≥ 15 days
Infusions for end-of-life or palliative care
Frequent phlebotomy in patients who have difficult/poor peripheral venous access, duration of stay ≥ 6 days
Intermittent infusions in patients who have difficult/poor peripheral venous access, duration of stay ≥  6 days
Need for central venous access in a critically ill patient when access is needed for ≥ 15 day
(Woller et al., 2016)

Complications of PICCs include (but are not limited to) accidental withdrawal, catheter fracture, catheter migration, infection, thrombosis, hematoma, and occlusion (Bing et al., 2022; Chopra et al., 2022; Duwadi et al., 2018; Fohlen et al., 2022; Gorski et al., 2021; Smith et al., 2017; Vaughn et al., 2020; Woller et al., 2016).

Central Venous Catheters: Femoral, Jugular, Subclavian

A central venous catheter can be inserted through the femoral, jugular, or subclavian vein (Berry, 2022). These catheters should be placed using ultrasound guidance (Gorski et al., 2021). These CVADs are sometimes referred to as non-tunneled central IV lines.

Insertion complications include carotid artery puncture when using the internal jugular vein, hematoma, hemothorax, and pneumothorax. Post-insertion complications include catheter occlusion, central line-associated bloodstream infection, and thrombosis (Berry, 2022; Gorski et al., 2021; McConville & Patel, 2015). (Note: Post-insertion complications will be discussed in a later section of the module).

The femoral, jugular, and subclavian insertion sites each have advantages and disadvantages in terms of insertion complications (Gorski et al., 2021). However, the differences - if there are any - between femoral, jugular, and subclavian insertion sites for the risk of complications after insertion are uncertain (McConville & Patel, 2015; Sakuraya et al., 2022). Gorski et al. (2021) noted that the femoral site is associated with a higher risk for infection, and the subclavian site has a higher risk for thrombosis. Sakuraya et al. (2022) performed a network meta-analysis of published literature. The authors found that the risk for catheter-related infections and mechanical complications, such as bleeding, hematoma, hemothorax, and pneumothorax, differed between insertion sites, but not always. For example, there were no significant differences between the sites for thrombotic complications. However, the literature they reviewed included PICC insertion and differences in study designs, and the patient populations that were studied complicated the analysis. The authors concluded: "based on the current literature, the most acceptable site for central venous catheterization is inconclusive, considering various complications in hospitalized patients"(Sakuraya et al., 2022).

Central Venous Catheter: Tunneled

Tunneled and non-tunneled central venous catheters are often used for acute and chronic hemodialysis. They are also used to treat patients who have acute kidney injury, patients who have been poisoned and need immediate removal of the drug, and for long-term venous access to deliver medications and TPN (Flick & Winters, 2022; Gorski et al. l., 2021; You & Oliver, 2022).

A tunneled central venous catheter has an access site; the catheter goes underneath the skin (an incision is made for this); the catheter incision travels down the vein, and the tip is positioned in the superior vena cava. Often, there is a cuff on the part of the catheter underneath the skin, which helps anchor the catheter. Some tunneled central venous catheters have an access site underneath the skin, accessed by needle puncture (Flick & Winters, 2022).

Central Venous Catheter: Non-Tunneled

Non-tunneled catheters are very similar to tunneled catheters in their design and function; however, they are used very differently. A non-tunneled catheter goes directly into the vein and does not pass under the skin. There is an entry site but not an exit site.

Like a tunneled catheter, non-tunneled ones are made up of a thin, long tubing that is open, allowing medications to go to the patient. Some non-tunneled catheters have single-lumens or multiple-lumens, allowing multiple solutions and medications to pass. Compared to tunneled catheters, non-tunneled catheters are easier to use (Clark et al., 2016).

Non-tunneled catheters are for temporary use, like standard IV therapy or checking labs. Non-tunneled catheters do not require incision and are usually used for two weeks or less (You & Oliver, 2022).

Though there are key similarities between these two types of catheters, significant differences must be noted.

  • Insertion – The insertion technique is a significant way tunneled and non-tunneled catheters differ. Non-tunneled catheters are inserted straight into the vein, without tunneling, while tunneled catheters pass under the skin and have both an entry and exit site (Clark et al., 2016).
  • Design- Tunneled catheters have an extra cuff near the entry site that non-tunneled catheters do not have. The cuff helps to prevent microbes and bacteria from gathering around the entry site.
  • Usage- Tunneled and non-tunneled catheters have different purposes and are used for different tasks. As discussed above, non-tunneled catheters are better used for standard IV therapy and for a short time. Tunneled catheters are inserted for long-term purposes such as chronic illnesses (Clark et al., 2016).
  • Safety- Both types of catheters have different risks and safety levels. Even though tunneled catheters have a cuff to prevent the accumulation of microbes and bacteria, the insertion process is more complex, increasing the risk of infections and other complications.
  • Duration- While non-tunneled catheters are not meant to be in place for long, tunneled catheters are designed to be in place for a minimum of a few weeks or even months, depending on their use (Mendu et al., 2017).

Totally Implantable (Ports)

Implanted ports are often used for patients requiring long-term care. Implantable ports are placed subcutaneously under the skin and are made up of titanium or plastic portals with a silicone tube that self-seals and a flexible tube or catheter. Implanted ports are placed on the right or left side of the chest. The catheter on the port flows from the skin and is placed above the heart's right atrium, under the collarbone. Occasionally, ports may be implanted in the stomach to deliver the medication near the tumor. Port-a-Cath, PassPort, Medi-port, and Infusaport are other names for an implanted port. Even though the port is placed under the skin, there is a small bulge where the port is, and it can be felt under the skin (Zhou et al., 2022).

The port is a common choice for patients with cancer requiring extended or long-term treatment. Patients usually have an implanted port placed during surgery. After placement, checks are done to confirm the port is positioned correctly so that the port can be used immediately.

There are single and double ports. Double ports look like two drums together.

Care providers stick a needle into the skin and through the port's septum to deliver medication. Blood can also be drawn from a port if necessary. After treatment is finished, ports can be easily removed (Machat et al., 2019).

Coated and Impregnated Catheters

Sometimes, catheters are impregnated or coated to prevent central line infections. It is commonly used in non-tunneled catheters that will be used for a short time or patients undergoing stem cell transplants. Commonly used agents include silver sulfadiazine, chlorhexidine, or rifampin (Lai et al., 2016a).

Catheters can be impregnated or coated with antibiotics, antimicrobials, or antimycotics to decrease the accumulation and growth of bacteria, reducing catheter-related infections (Lai et al., 2016a).

CVAD Insertion

A PICC or an internal jugular, femoral, or subclavian CVAD should be inserted using these basic principles.

  1. Use a CVAD with the fewest number of lumens. Research indicates a strong association between the number of PICC lumens and the risk of complications, such as central-line associated bloodstream infections (CLABSI), venous thrombosis, and catheter occlusion (Gorski et al., 2021; Woller et al., 2016; Bozaan et al. 2019).
  2. Use the smallest size catheter. A large catheter in a small blood vessel, i.e., a high catheter-to-vein ratio, can increase the risk for a thrombus and phlebitis (Gorski et al., 2021; Sharp et al., 2015).
  3. Use ultrasound to insert the CVAD (Gorski et al., 2021). The use of ultrasound reduces the number of insertion attempts and decreases the duration of the insertion procedure. It is likely to decrease the number of mechanical complications of insertion like arterial puncture, hematoma, and pneumothorax, and it may decrease the risk of developing a CLABSI.
  4. Optimal catheter tip placement: The correct placement of the tip of a CVAD can help prevent complications like infection and thrombus formation (Gorski et al., 2021; Sharp et al., 2015).

Insertion Complications

Many complications can occur during CVAD insertion; fortunately, serious/dangerous complications like cardiac events seldom happen. The complications discussed here are familiar to most nurses, if not in the context of a CVAD insertion, then from their day-to-day clinical experience and the body of knowledge they have. The list presented here is not all-inclusive; some CVAD insertion complications are uncommon, and only a few cases have been documented. CVAD insertion complications can be minor, e.g., bleeding or nerve injury that quickly resolves, but dangerous arrhythmias, pneumothorax, and significant bleeding can occur.

  • Arrhythmias: Arrhythmias caused by CVAD placement rarely occur. They can occur during PICC placement and placement at other insertion sites, and asystole, atrial fibrillation, complete heart block, and ventricular tachycardia have been reported (Golamari et al., 2019). Nine dangerous arrhythmias that occurred during 12,388 CVAD insertions, an incidence of 0.07%, have been reported. Information on arrhythmias and CVAD insertion are scant.
  • Arterial puncture: An arterial puncture has been reported to occur in up to 12% of CVAD insertions. Treatment options for this complication include immediate removal of the catheter and application of manual pressure or leaving it in place until another removal method can be used. An arterial puncture can cause serious complications, including (but not limited to) bleeding, dissection of the vessel, hemothorax, and pseudoaneurysm (Patel et al., 2021). Note: A pseudoaneurysm is a hematoma inside the wall of a blood vessel that has been injured by trauma – in the case of insertion, the catheter or the guidewire punctures the blood vessel.
  • Hematoma: Hematoma formation has been reported to occur in 4.7% of CVAD placements, and a hematoma can cause compressive nerve injury (Gorski et al., 2021; Patel et al., 2021).
  • Hemothorax: Hemothorax can occur during CVAD insertion, but it appears rare; this is when blood collects between the lungs and chest wall.
  • Laceration: A blood vessel or right atrium laceration can occur during CVAD placement (Patel et al., 2021).
  • Malposition: Researchers have retrospectively reviewed information on 2045 central venous catheter insertions. The authors defined catheter malposition as ". . . unintended placement of the catheter in a vessel other than the intended superior vena cava." There were 275 (13.4%) instances of catheter malposition.
  • Nerve injury: Jugular and subclavian CVAD insertion can cause phrenic nerve injury, often causing trouble breathing (Gorski et al., 2021). Inserting a CVAD into the internal jugular vein can damage a sympathetic nerve, disrupt sympathetic outflow to a specific area, and cause Horner syndrome. Horner's syndrome is a rare complication of CVAD insertion that is characterized by facial anhidrosis (absence/lack of sweating), enophthalmos (eyes are sunken in), miosis (pupillary constriction), and drooping of the eyelids. Data on nerve injury is scant, but 1 case of nerve injury lasting > 72 hours in 9118 CVAD insertions in the internal jugular vein with an incidence of 0.01% has been reported.
  • Pneumothorax and other pulmonary complications: Researchers have retrospectively reviewed information on 2045 central venous catheter insertions, and there were 14 (0.7%) occurrences of pneumothorax. Other pulmonary complications of CVAD insertion include air embolism (which can occur post-insertion), pneumomediastinum (air in the chest between the lungs), and tracheal injury (Patel et al., 2015).

Post-Insertion and Post-Insertion Complications

The location of the CVAD tip should be checked immediately after insertion, and the tip position should be checked if a CVAD tip may have moved, i.e., the patient has been transported or there is excessive arm movement. Tip locations can be found using an x-ray, an electrocardiogram (ECG), or an ultrasound (Gorski et al., 2021; You et al., 2022).

A chest x-ray is sufficient for locating the CVAD tip (Gorski et al., 2021). However, the proper location of the tip, the cavoatrial junction, cannot be seen with an x-ray (Gorski et al., 2021). With this technique, CVAD tip location must be estimated using anatomical landmarks and measuring (Gorski et al., 2021).

Checking the CVAD tip position by ECG is done by connecting an ECG wire to the insertion guide wire. The CVAD tip position is determined by specific p-wave changes on the ECG. Using an ECG is superior to an x-ray. An installation of normal saline in the catheter lumen and an ECG can also be done (Gorski et al., 2021; Yu et al., 2022).

Ultrasound has been used successfully for checking CVAD tip location (Smith et al., 2017). However, Gorski et al. (2021) wrote: "The clinical applicability of this is currently limited by the small sample sizes used to demonstrate its efficacy . . . and its usefulness is limited by the knowledge, skill, and experience of the operator."

Post-insertion complications of CVADS will be covered in this section; monitoring for and preventing complications will be discussed later in the module. The complications discussed here are the ones that are common or most likely to occur.

Catheter-Line Associated Bloodstream Infections

CLABSIs are defined as the presence of bacteria that have originated from the catheter.

These four criteria define a CLABSI.

  1. A laboratory-confirmed bloodstream infection
  2. The patient has had a CVAD in place for > two days
  3. The CVAD has been in place on the day of, or the day before, the first sign or symptoms
  4. The infection cannot be attributed to another infection (Alotaibi et al., 2020)

It has been estimated that each year in the US, in acute care settings, there are approximately 30,000 to 40,000 CLABSIs diagnosed. CLABSIs are associated with prolonged hospital stays and increased mortality (Alotaibi et al., 2020; Buetti et al., 2022; Huerta et al., 2018; Selby et al., 2021). The worldwide mortality rate from CLABSI has been reported to be up to 20% (Niemann et al., 2022).

  • Causes: A CVAD can become infected during the insertion and/or when it is in place (Gorski et al., 2021; Selby et al., 2021). Post-insertion contamination can occur during dressing changes; it can be caused by poor hand hygiene, the catheter hub and/or lumen can become contaminated during manipulation or routine use, and the catheter may become contaminated when a microorganism moves from another infection site to the CVAD (Gorski et al., 2021; Selby et al., 2021). Many CLABSIs are caused by a failure to correctly do CVAD maintenance care (Gorski et al., 2021; Lutwick et al., 2019; Selby et al., 2021).
  • Risk factors: Risk factors for CLABSI are listed in Table 4.
Table 4: Risk Factors for CLABSI
Biofilm
Body mass index > 40
Concurrent catheter placement
Dialysis
ICU admission
Immunocompromised
Intraoperative
Multi-lumen catheters
Neutropenia
Parenteral nutrition
Prolonged duration of catheterization
Prolonged duration of hospitalization
Nurse-patient ratio
Significant microbial colonization of the catheter hub
Substandard catheter care
(Buetti et al., 2022; Fisher et al., 2020; Niemann et al., 2022; Selby et al. 2021)
  • Biofilm: A biofilm is a microorganism that attaches to a surface and then forms a polymeric substance. The substance helps them attach to a surface, like a central venous catheter. By several complex mechanisms, biofilms protect the microorganism, prevent its eradication by the immune system, and decrease the effectiveness of antibiotics (Niemann et al., 2022; Selby et al., 2021). Biofilms are a well-known risk factor for CLABSI (Niemann et al., 2022). Bacterial colonization of a vascular catheter can happen very quickly, within 24 hours of insertion. A biofilm can form within 48 to 72 hours after a central venous catheter has been placed (Higgins et al., 2021).
  • Signs and symptoms: Signs and symptoms of insertion site infection are obvious and include drainage, edema, erythema, fever, pain, and swelling. A diagnosis of CLABSI is considered when the patient has signs/symptoms of sepsis, and the diagnosis is confirmed by blood cultures, including cultures of the catheter tip (Gorski et al., 2021).

Unless it is necessary to try and salvage the catheter, e.g., alternative IV access is absent or will be very difficult, CLABSI is typically managed by removing and replacing the catheter and with antibiotic therapy (Haddadin et al., 2022).

Air Embolism

Air embolism is a very uncommon complication of CVAD placement, either during or after insertion. A venous air embolism occurs when air enters the IV system due to a disruption/leak in its patency. Air enters the bloodstream and moves to the right ventricle, the lungs, and sometimes to the brain. An air embolism is potentially fatal (Abramson et al., 2020; Khaliq et al., 2018). Signs and symptoms of air embolism include (but are not limited to) altered mental status, coughing, dyspnea, hypotension, tachycardia, and wheezing (Gorski et al., 2021).

There are a few common diagnostic modalities used to diagnose an air embolism.

  • An EKG can be done and usually shows strain on the right side of the heart, tachycardia, and T-wave changes.
  • End-tidal carbon dioxide (ETCO2) may show a decrease in numbers, indicating an air embolism.
  • Chest x-ray or CT scan may show enlargement in the pulmonary artery or trapped air in the artery.
  • A transthoracic echocardiography may show trapped intra-cardiac air but is an intense procedure to be performed and often a last resort (McCarthy et al., 2017).

There are many interventions that providers may perform to alleviate an air embolism; they include:

  • Hemodynamic support, including standard IV therapy, vasopressors, and inotropes (medications that tell the heart to contract with more/less power).
  • High-flow, 100% oxygen; if necessary, hyperbaric oxygen may be used to decrease the partial pressure of nitrogen in the blood, thereby reducing the size of the air embolism.
  • The patient should be placed in a left lateral decubitus position called Durant's maneuver. If the patient is hemodynamically unstable, the patient should be placed in the Trendelenburg position.
  • An emergent cardiopulmonary bypass is warranted if the patient is unstable.
  • CPR with high-quality chest compressions is necessary if the patient is in cardiovascular collapse or arrest (McCarthy et al., 2017).

Catheter Damage

Catheter damage is uncommon, but a CVAD can fracture and form an embolism, and the external section of a CVAD  can develop a crack or a hole (Gorski et al., 2021). A catheter can contribute to an embolism in several ways; it can become separated from the implanted port, a catheter can become fractured during a catheter exchange, or pinch-off syndrome can occur (Gorski et al., 2021).

Pinch-off syndrome is a rare and potentially fatal complication caused by anatomic compression of the catheter (Caiazzo et al., 2022; Gorski et al., 2021; Lakshmi et al., 2022). It appears that it occurs most often with subclavian lines that have been in situ for a long duration (Caiazzo et al., 2022; Chuah et al., 2021). Signs and symptoms of the pinch-off syndrome include (but are not limited to) arrhythmias, cardiac perforation, cough, dyspnea, endocarditis (inflammation of the heart), and sepsis (Caiazzo et al., 2022; Chuah et al., 2021).

Catheter Migration

A CVAD tip can migrate at any time after insertion. The tip can move to the mediastinum (the area between the lungs), the pericardium (the area around the heart), the pleura (thin layer covering lungs), and the trachea, causing thrombosis and serious complications like hemothorax and pericardial effusion (excess fluid around the heart). Migration of a CVAD tip can be caused by coughing, a thrombosis, positive-pressure ventilation, physical activity like arm or neck movement, vomiting, or congestive heart failure (Gorski et al., 2021; Martinez and Puller, 2021).

Deep Vein Thrombosis (DVT)

DVT is a well-described complication of PICCs and other types of CVADs (Bing et al., 2022; Duwadi et al., 2018; Gorski et al., 2021; Grau et al., 2017; Sakuraya et al., 2022; Citla Sridhar et al., 2020; Swaminathan et al., 2022; Yuen et al., 2022). The incidence of central line-associated DVT varies, depending on the patient population and other factors. It has been estimated that 10% of all DVTs in adults and 50% to 80% of all DVTs in children are associated with a central line catheter (Citla Sridhar et al., 2020).

The vascular endothelium (the inner cellular lining of veins, arteries, and capillaries) prevents blood clotting and platelet adhesion (Citla Sridhar et al., 2020; Wang et al., 2018). Central venous access placement disrupts these functions. By blocking contact of blood with the endothelium, a CVAD changes the structural integrity of the endothelium and becomes a risk factor for DVT formation (Citla Sridhar et al., 2020; Wang et al., 2018).

The risk factors for central line-related DVTs are listed in Table 5. The risk factors are patient-related, insertion-related, and catheter-related.

Table 5: Risk Factors for Central IV Line-Associated DVT
Age: Increased age is associated with increased risk
Pre-existing Conditions: Cancer (especially metastatic), catheter infection, chemotherapy, critical illness, hypercoagulability (acquired or hereditary), WBC < 12,000, radiotherapy treatment to the thorax, systemic infection
Insertion site, femoral, internal jugular, subclavian: The data indicate no significant difference in DVT risk between these sites
Insertion site, PICC: The data is conflicting and inconclusive as to whether a PICC line has an increased risk of DVT compared to the three other insertion sites
Number of insertion attempts: The data is conflicting
The catheter tip location is misplaced
Catheter to vein ratio: Higher ratio, higher risk
Duration of placement: Data is unclear if the duration of time increases the risk
A multi-lumen catheter
Presence of another catheter
(Gorski et al., 2021; Citla Sridhar et al., 2020; Sakuraya et al., 2022; Puri et al., 2022; White et al, 2018; Sharp et al., 2015)

Most patients with a central line-associated DVT are asymptomatic (Gorski et al., 2021; Citla Sridhar et al., 2020). Signs and symptoms of a CVAD-associated DVT include edema and/or pain in the chest, neck, or an extremity, erythema and/or numbness in an extremity, difficulty moving the extremities and/or the neck (Li & Lu, 2022; Gorski et al., 2021). Signs and symptoms of a pulmonary embolism include (but are not limited to) chest pain, diaphoresis (increased sweating), dyspnea, pleuritic pain, and tachycardia (Gorski et al., 2021).

A DVT is usually detected and diagnosed using duplex ultrasonography (Citla Sridhar et al., 2020). If a DVT is present and the CVAD is functional, and it is still needed, the current recommendations are to leave it in (Gorski et al., 2021; Citla Sridhar et al., 2020).

Infiltration and Extravasation

Infiltration occurs when the IV catheter dislodges from the vein, and IV fluid infuses into the surrounding tissue. Signs and symptoms of infiltration include swelling in and around the area. Infiltration usually does not cause significant pain, but infiltration of certain medications, like chemotherapy drugs, can cause serious tissue damage (Brock & Cruz-Carreras, 2020; Masood et al., 2022).

Extravasation is an infiltration; the IV catheter dislodges from the vein, and IV fluid moves into the tissue. The difference between infiltration and extravasation is the type of IV fluid and the consequences. Extravasation occurs when the IV medication is very irritating or a vesicant (Gorski et al., 2021). A vesicant is an agent capable of causing tissue damage when it escapes from the intended vascular pathway into surrounding tissue (Gorski et al., 2021). Drugs and other substances that are or can be vesicants include (but are not limited to) chemotherapy drugs, IV contrast media,  50% dextrose, TPN, and vasopressors, as discussed above (Cho et al., 2019; Brock & Cruz- Carreras, 2020; Lawson et al., 2013; Masood et al., 2022; Shrestha et al., 2020). Extravasation can cause irritation, pain, tissue necrosis, compartment syndrome (a painful condition from pressure in the muscles), amputation, sepsis, and death (Abdel al. et al., 2022;  Brock & Cruz-Carreras, 2020; Chinn & Colella, 2017; Masood et al., 2022). The signs and symptoms of extravasation can be delayed (Karius & Colvin, 2021).

Occlusion

Occlusion of a CVAD is common; it has been estimated that as many as 25% of patients with CVADs develop an occlusion (Ast & Ast, 2014).

Occlusion of a CVAD can be usefully divided into 1) chemical occlusion, 2) mechanical occlusion, and 3) thrombotic occlusion (Gorski et al., 2021; Ornowska et al., 2022).

  • Chemical occlusion: Chemical occlusion of a CVAD can be caused by precipitates of medications, such as crystals,  and/or components of TPN like calcium, phosphate, or lipids (Ast & Ast, 2014; Gorski et al., 2021; Ornowska et al., 2022).
  • Mechanical occlusion: Mechanical occlusion of a CVAD can be external or internal (Ast & Ast, 2014). External occlusions can be in the IV tubing, the external part of the CVAD, or a filter, and they can be caused by the movement of a patient's head or neck (Ast & Ast, 2014; Gorski et al., 2021). Internal mechanical occlusion can be caused by a biofilm, kinks, catheter malposition, catheter migration, or pinch-off syndrome (Gorski et al., 2021; Ornowska et al., 2022).
  • Thrombotic occlusion: A DVT is an example of a thrombotic occlusion. Symptoms include pain, swelling, redness, and numbness (Gorski et al., 2021; Ornowska et al., 2022).

Signs and symptoms of CVAD occlusion, in general, include the inability to aspirate blood, a slow/sluggish blood return when aspirating, slow/poor infusion rate, inability to infuse, infusion pump alarms, and leaks and/or swelling at the insertion site (Gorski et al., 2021).

Phlebitis

Phlebitis is an inflammation of the inner layers of a blood vessel (Lu et al., 2022). Phlebitis associated with a CVAD can be caused by chemical, infectious, and mechanical factors, patient-related factors, and rarely, post-infusion phlebitis (Gorski et al., 2021; Webster et al., 2015).

There is little current information about the risk for and incidence of phlebitis and femoral, jugular, and subclavian CVADs. Lu et al. (2022) found that the reported rate of phlebitis in PICCS was 0.6% to 9.7%. Most published information on catheter-related phlebitis concerns peripheral IVs (Gorski et al., 2021).

  • Chemical phlebitis: Chemical phlebitis can be caused by IV solutions with extremes of pH or osmolarity like dextrose solutions > 10% concentration, 3% sodium chloride, or by drugs like amiodarone (treats arrhythmias), chemotherapy drugs, potassium, and antibiotics like vancomycin (Gorski et al., 2021; Heng et al., 2020; Woods et al., 2022).
  • Infectious phlebitis: Infectious phlebitis can be caused by contamination of the catheter and/or the insertion site (Gorski et al., 2021).
  • Mechanical phlebitis: Mechanical phlebitis with vein irritation can be caused by a catheter that is too large in relation to the size of the blood vessel and the movement of the catheter after insertion (Gorski et al., 2021).
  • Patient-related factors: Female patients, patients with diabetes, patients who are immunocompromised, and/or are ≥ age 60 have an increased risk for catheter-related phlebitis (Gorski et al., 2021).
  • Post-infusion phlebitis: Post-infusion phlebitis occurs after an IV catheter has been removed (Gorski et al., 2021; Webster et al., 2015). Post-infusion phlebitis can be caused by any of the factors mentioned above, and the incidence of this complication has been reported to be from 0% to 23%. Post-infusion phlebitis can occur up to 48 hours after removing an IV catheter (Gorski et al., 2021). Webster et al. (2015) found that in the patient population they studied, 75% of the patients who developed post-infusion phlebitis did not have phlebitis when the catheter was removed.

Signs and symptoms of phlebitis include erythema, induration, pain, redness, swelling, and a palpable venous cord (Gorski et al., 2021; Webster et al., 2015). Gorski et al. (2021) recommend using a phlebitis assessment scale and observable data to rate the severity of an IV catheter-related phlebitis. Several phlebitis assessment scales are available, e.g., the Venous Infusion Phlebitis (VIP) scale. However, it is unclear if they are valid assessment scales or how good their inter-observer/rate reliability is (Gallant & Schultz, 2006; Gorski et al., 2021).

Nursing Care of a Patient with a CVAD

Nursing care for a patient who has a CVAD involves:

  1. Assessment of the infusion system
  2. Assessment of the insertion site
  3. Dressing changes
  4. CVAD flushing and locking
  5. Observing for complications
  6. Preventing complications 

The fifth one has been covered in the "Complications of Central Venous Access Devices" section.

Assessment of the Infusion System

The infusion system should be routinely assessed (Gorski et al., 2021). This assessment should include the solutions and solution containers, the infusion pump/infusion device, the IV tubing, IV connections, the insertion site dressing, and the insertion site (Gorski et al., 2021). Standard Precautions, such as personal protective equipment like gloves and masks, should always be used during this assessment, especially hand hygiene and safe injection practices. Other infection control techniques like bloodborne and contact precautions should be used as needed. Sterile technique should be used for the parts of the assessment that require it. Each healthcare facility or organization will have a guideline for the frequency of this assessment.

Assessment of the Insertion Site

The CVAD insertion site should be routinely assessed for signs of infection and to ensure that the CVAD is securely attached. Signs and symptoms of insertion site infection are obvious, including drainage, edema, erythema, fever, pain, and swelling (Gorski et al., 2021).

A secure attachment of a CVAD prevents the CVAD from moving and from accidental removal. The attachment of the CVAD should be assessed each time the insertion site is assessed for infection (Gorski et al., 2021). Each healthcare facility/organization will have its own guideline for the frequency of this assessment.

Dressings and Dressing Changes

A CVAD can be dressed in a chlorhexidine-impregnated dressing, sterile gauze, or a transparent semipermeable membrane called a TSM (Gorski et al., 2021; Lutwick et al., 2019; Selby et al., 2021).

Sterile gauze is preferred if there is drainage at the insertion site or if the patient is sweating excessively (Gorski et al., 2021; Lutwick et al., 2019). For all other situations, a TSM is recommended as a transparent dressing allows for easy inspection of an insertion site, and TSMs may reduce the risk of CVAD dislodgement/removal (Gorski et al., 2021; Lutwick et al., 2019).

Chlorhexidine-impregnated CVAD dressings may decrease the risk of insertion site infection compared to other dressings (Lutwick et al., 2010; Selby et al., 2021). A chlorhexidine-impregnated dressing should be used if the patient is ≥ 18 years of age and they have a non-tunneled CVAD or if other techniques for preventing a CLABSI have not worked (Gorski et al., 2021).

A sterile gauze dressing should be changed at least every two days, and a sterile gauze dressing should be changed if it is damp, loose, or soiled (Gorski et al., 2021; Lutwick et al., 2019; Selby et al., 2021).

A TSM dressing on a CVAD should be changed at least every seven days, and a TSM should be replaced immediately if it is loose or soiled or if blood, drainage, or moisture is underneath the TSM (Gorski et al., 2021).

Gorski et al. (2021) recommend cleaning the skin around the CVAD insertion site and the area that the dressing will cover with alcohol-based chlorhexidine solution (Gorski et al., 2021). Compared with povidone-iodine, an alcohol-based chlorhexidine solution may or may not reduce bacterial growth in the area and reduce the incidence of CLABSI (Bakir et al., 2021; Lai et al., 2016b; Lin et al., 2022). Povidone-iodine or 70% isopropyl alcohol can be used if needed (Gorski et al., 2021).

Do not routinely apply an antimicrobial ointment to the CVAD insertion site (Gorski et al., 2021; Lutwick et al., 2019).

Each healthcare facility/organization will have its guideline for the frequency of CVAD dressing changes.

CVAD Flushing and Locking and Disinfecting Access Ports

Flushing and locking are essential for the prevention of CVAD occlusion and CLABSI. Flushing cleans the CVAD; locking ensures that it remains patent between uses and helps to prevent CLABSI (Gorski et al., 2021; Selby et al., 2021).

Flushing: Routine and Post-Medication Administration

  1. Disinfect the catheter access site before flushing (Gorski et al., 2021); this process is explained in the next section.
  2. Use a 10 mL syringe or a 10 mL barrel syringe (which generates a lower pressure) to flush a CVAD (Gorski et al., 2021).
  3. Aspirate before flushing (Gorski et al., 2021).
  4. Flush the CVAD with 0.9% sodium chloride that is preservative-free (Gorski et al., 2021). If using a sodium chloride solution that has benzyl alcohol in it, do not use more than 30 mL in 24 hours. Do not use sterile water to flush a CVAD (Gorski et al., 2021).
  5. It is recommended to use a pulse technique to flush a CVAD, i.e., a 1 mL bolus, a short pause, and then a repeat (Gorski et al., 2021). Studies have shown – but not proven – that this technique may decrease bacterial contamination in a CVAD lumen, remove solid deposits in the lumen, and decrease the accumulation of material that can obstruct the lumen (Ferroni et al., 2014; Gorski et al., 2021; Goossens, 2015). Clinical studies are needed to clarify the true effect of this technique.
  6. Gorski et al. (2021) recommend flushing with a volume that is twice the volume of the internal volume of the catheter system, i.e., the catheter and add-on devices. Up to 10 mL may be needed for a CAVD.
  7. Do not use force to flush a CVAD.
  8. Blood can reflux back into the flushing syringe and push the plunger back. To prevent this, leave 0.5 to 1 mL of the flush solution in the syringe, or use a pre-filled syringe designed to prevent this (Gorski et al., 2021).
  9. A central IV line should be flushed after infusion of medication; the frequency of CVAD flushing aside from that should be covered by a healthcare facility's protocol. Use enough flushing solution to remove all medication from the administration set and CVAD lumens (Gorski et al., 2021).

Disinfecting Access Ports

  1. Access port disinfection should be done before every use.
  2. Access port disinfection can be done actively or passively (Gorski et al., 2021; Helder et al., 2020; Voor In 't Holt et al., 2017; Rickard et al., 2021).
  3. Active port disinfection can be done with 70% isopropyl alcohol, alcohol-based chlorhexidine, or povidone-iodine (Gorski et al., 2021; Rickard et al., 2021).
  4. Passive disinfection is done by covering the access port with a cap or some type of cover containing a disinfectant, and the cap/covering is left on for a specific amount of time. Research indicates that passive disinfection can prevent CLABSI (Helder et al., 2020; Voor In 't Holt et al., 2017; Tejada et al., 2022).

Locking

  1. Use heparin, 0.5 to 1 unit/10 mL, or 0.9% sodium chloride (Gorski et al., 2021).
  2. Gorski et al. (2021) noted that there is no evidence that either solution is superior for muti-lumen, non-tunneled CVADs or PICCs, and the authors of a recent literature review wrote that they were uncertain whether intermittent locking with heparin results in fewer central venous catheter occlusions than intermittent locking with normal saline in adults. Low-certainty evidence suggests that heparin may have little or no effect on catheter patency duration. There was no evidence of differences in safety (central venous catheter-related bloodstream infections, mortality, or hemorrhage) (López-Briz et al., 2018).
  3. Definitive answers regarding when and how often locking should be done, the optimal dwell time, what solution should be used (at times, a solution other than heparin or 0.9% sodium chloride may be used), and for whom locking should be done are not available (Gorski et al., 2021; Selby et al., 2021). Evidence shows that locking can prevent central line infections (Selby et al., 2021). Gorski et al., 2021 provided recommendations for some of these questions; follow the protocol of the health care facility/organization.

Preventing CVAD Complications

Central Line-Associated Bloodstream Infections (CLABSIs)

  • Care Bundle: A care bundle of interventions like chlorhexidine gluconate baths, clinician education, and using antiseptic/antimicrobial-coated catheters is a proven way to reduce CLABSIs, and it is universally recommended (Buetti et al., 2022; Centers for Disease Control and Prevention [CDC], 2020; Gorski et al., 2021; Lutwick et al., 2019; Selby et al., 2021). A care bundle is a primary method of preventing CLABSIs. The interventions and therapies included in the bundle will (likely) differ depending on the facility (Buetti et al., 2022). The interventions and therapies included in this section are done before and after CVAD insertion. Post-insertion interventions, i.e., maintenance therapies, are a primary part of nursing care. They should be conscientiously followed because many CLABSIs are caused by a failure to correctly do CVAD maintenance care (Lutwick et al., 2019).
  • Access port disinfection: It is recommended as a part of the CLABSI prevention bundle (Buetti et al., 2022). It was discussed more thoroughly earlier in the course.
  • Antimicrobial lock solutions: It was discussed more thoroughly earlier in the course; it is recommended as a part of the CLABSI prevention bundle (Gorski et al., 2021).
  • Antiseptic/antimicrobial-coated catheters: A CVAD that is impregnated with an antimicrobial agent (minocycline-rifampin) or an antiseptic (chlorhexidine-silver sulfadiazine) can reduce the risk of developing a CLABSI (Buetti et al., 2022; Lutwick et al., 2019; Selby et al., 2021). These catheters are typically used 1) if the CLABSI rate of the facility is higher than expected, 2) if the catheter will be in place for a long time, 3) the patient has limited venous access, or 4) the patient has a history of CLABSIs (Buetti et al., 2022, Lutwick et al., 2019; Selby et al., 2021).
  • Chlorhexidine dressings: There is good evidence that a chlorhexidine dressing reduces the risk for CLABSI, and a chlorhexidine dressing is considered an essential part of the CLABSI prevention bundle (Buetti et al., 2022). Buetti et al. (2002) recommend their use for all patients >2 months of age; Gorski et al. (2021) recommend their use if the patient is ≥ 18 years of age and they have a non-tunneled CVAD or if other techniques for preventing a CLABSI have not worked (Gorski et al., 2021).
  • Chlorhexidine gluconate baths: Daily bathing with chlorhexidine gluconate decreases the rate of CLABSI (Reynolds et al., 2021; Selby et al., 2021). Evidence for the effectiveness of this therapy is primarily from its use for critically ill patients in the ICU (Selby et al., 2021). Evidence shows that a daily chlorhexidine bath can prevent CLABSI in non-ICU patients (Buetti et al., 2022; Selby et al., 2021). Daily chlorhexidine baths for ICU patients ≥ 2 months of age are one of the recommended parts of the CLABSI prevention bundle (Buetti et al., 2022; CDC, 2020; Gorski et al., 2021).
  • CVAD removal: The need for a CVAD should be evaluated every day, and a CVAD that is not essential should be removed (Buetti et al., 2022; CDC, 2020).
  • Education and competency assessment: Educating healthcare professionals involved in inserting CVADS and caring for patients with a CVAD and periodically assessing their competence in these skills is a recommended part of a CLABSI prevention bundle (Buetti et al., 2022). Gorski et al. (2021) stress the importance of education and competency assessment, and the authors wrote: "Acknowledge that the length of clinical experience and passive recurrent performance are not surrogates for clinical knowledge and procedural competence . . . "
  • Insertion site evaluation: It was previously discussed; the site should be evaluated for signs and symptoms of infection (Gorski et al., 2021).
  • Nurse-patient ratio: A sub-optimal nurse-patient ratio has been identified as a factor that increases the risk of developing a CLABSI (Scheier et al., 2021). Buetti et al. (2022) recommend an appropriate nurse-patient ratio and avoiding using float nurses as part of the CLABSI prevention bundle.

The primary ways of preventing an air embolism are maintaining the integrity of the infusion system, such as preventing accidental disconnections and removing all air from an infusion system before starting therapy (Gorski et al., 2021).

Catheter damage: Catheter damage can be prevented partly by using non-forced flushing and ensuring the CVAD is not bent or kinked (Gorski et al., 2021).

Catheter migration: Nursing care may not prevent catheter migration. However, it is important to know the relatively benign signs and symptoms of catheter migration, like poor flow and no blood return, and the serious signs of catheter migration, like arrhythmias and pneumothorax (Gorski et al., 2021).

DVT: Know the risk factors for DVT and know that a CVAD-associated DVT is clinically silent in most cases. Administer anticoagulation therapy, if prescribed, as this is the primary treatment (Stevens et al. 2021). 

Infiltration/extravasation: Knowing the signs, symptoms, and risk factors of infiltration and extravasation can prevent an air embolism.

Occlusion: Preventing an occlusion requires a nurse to know and to correctly use flushing and locking techniques (Gorski et al., 2021).

Phlebitis: Nursing care for preventing phlebitis involves using the proper techniques for insertion site cleaning, disinfection, and dressing changes (Gorski et al., 2021).

Central Line Removal

There are specific policies and protocols for central line removal, and they differ for each facility.

  • The first step is to apply and follow these related policies and protocols and confirm the order by the provider.
  • Hand hygiene and infection control should be followed before, during, and after the procedure. Equipment, such as an eye shield and non-sterile gloves for blood sampling, should be laid out in an accessible position (Kabra et al., 2015).
  • Two patient identifiers should be used to confirm patient identification.
  • A vascular consult or provider consult may also be necessary.
  • Coagulation tests should be performed to check platelets, INR, and PTT. If platelets are <50,000 or INR is >1.5, orders should be reviewed with a care provider. If the patient takes any coagulation medications, such as antiplatelet agents or anticoagulants, orders should also be reviewed with a physician. It is possible that platelets or plasma may be administered to reduce the risk of bleeding. After removal, additional site pressure may be warranted.
  • The bedside should be prepared, and the patient should be assessed. When removing a femoral venous catheter, the provider should use a bedside stool to keep them in an optimal position for pressure application while reducing strain on the back. Direct pressure should be applied to stop central or arterial venous catheter bleeding. The patient may be unable to lay flat during the procedure or while pressure is applied. Assistance may be needed for positioning, pressure, or blood cultures. A sedative and analgesic may be ordered and administered if the patient is uncooperative or restless. Inadequate pressure or contamination may occur if the patient is restless due to pain or improper positioning (Kabra et al., 2015).
  • The tray at the bedside should be prepared. Hand hygiene should be performed, and the central line dressing tray should be opened. Non-sterile gowns, gloves, masks, and face shields should be worn. Sterile scissors should be used for the suture line. Chlorhexidine may be necessary for device removal. Sterile petroleum gel should be applied to the center of a gauze square. Petroleum gel creates a barrier to prevent air and possibly bacteria from entering the catheter tract. However, this gel can make hemostasis challenging; care should be taken to ensure the petroleum gel does not enter the catheter tract and bloodstream before clotting (Kabra et al., 2015).
  • The old dressing should be removed and discarded while wearing non-sterile gloves. A swab stick may be necessary to help loosen the dressing. The site should be cleansed with chlorhexidine and allowed to air dry for at least two minutes.
  • The catheter should be removed. The head of the bed should be lowered, and the patient should be placed in the Trendelenburg position if possible. Dry gauze should be placed over the insertion site for ease of removal. If resistance is met, a provider of care or physician should be notified. The patient should be asked to hold their breath during the removal. The catheter should be pulled in a slow, steady motion. Direct and immediate pressure should be applied at the site for at least five minutes. Assess for bleeding and inspect the catheter to ensure it is intact. If damaged, the physician or provider of care should be notified. If warranted, the tip should be sent off for cultures (Burnham et al., 2018).

Arterial Catheters

Clinical Indications

Arterial catheters are used for short-term hemodynamic monitoring and when frequent blood gas analysis and blood sampling are needed; these are the primary uses of an arterial catheter (Berry, 2022; Gorski et al., 2021; Kaufmann et al., 2020). Invasive blood pressure measuring with an arterial catheter is recommended for and used most often for the treatment of 1) high-risk surgical patients, in selected cases, 2) critically ill patients, and 3) patients who are in shock (Gelb et al., 2018; Gorski et al., 2021; Kaufmann et al., 2020; Lakhal et al., 2018; Meidert et al., 2021; Saugel et al. 2020; See, 2022).

Most hospitalized patients can have non-invasive monitoring of their blood pressure by auscultation. Korotkoff sounds are what medical personnel listen for when they are taking blood pressure, and it is the pulsatile circulatory sounds heard upon auscultation of the brachial artery (Ramakrishnan, 2016). In patients who are unstable and/or critically ill, there may be a need for more invasive techniques to monitor blood pressure. In this instance, arterial catheterization is warranted. More indications for arterial lines include:

  • Frequent blood samples are needed
  • Continuous beat-to-beat monitoring of blood pressure
  • Administration of medications
  • The need for an intra-aortic balloon pump

Advances in design and use now allow arterial lines to monitor and calculate stroke volume and cardiac output. They can also monitor the response to fluid therapy when the patient is hypovolemic (Gelb et al., 2018; Gorski et al., 2021; Kaufmann et al., 2020; Lakhal et al., 2018; Meidert et al., 2021; Saugel et al. 2020; See, 2022).

Equipment

Facility policies and procedures should be adhered to. Some kits include everything needed for this procedure. Depending on the facility and policies, a Heparin 500ml bag with a pressure bag at 300mmHg is often used. An ICU monitor shows the numbers being monitored. Transducer kits should be calibrated and ready to go; the transducer should be level with the patient when the patient is flat to ensure correct readings. The monitoring device should be set to zero while the transducer hub is leveled (Saugel et al., 2020).

A wave test should also be performed as it shows a baseline arterial line waveform. Waveforms may be:

  • Normal- the shape of the waveform is from the closure of the aortic valve and the blood pressure (Foti et al., 2022).
  • Over-damped- this is more loss of energy; it can be caused by air in the tubing, kinks or clots in the tubing, or narrowed pulse pressure (Lam et al., 2021).
  • Under-damped- this can be caused by artifacts in the line, tachydysrhythmias (abnormal rhythm over 100 beats per minute), overestimation of systolic blood pressure, or underestimation of diastolic blood pressure (Foti et al., 2022).

Ensure the tubing is not kinked. Do not force the flush if the tubing or line does not flush. Forcing the flush could cause a thrombosis to dislodge and can be fatal for the patient (Nguyen & Bora, 2022).

Placement and Technique

Arterial catheters are usually placed in the radial artery (Chandrashekarappa et al., 2018; Hanrahan et al., 2022; Kumar & Geube, 2021; Saugel et al., 2020; Vidovich, 2018). Radial artery cannulation is technically easy; there is usually good collateral circulation if there is an occlusion of the radial artery, and complications are very uncommon (Hanrahan et al., 2022; Nuttall et al., 2016). The brachial, femoral, and ulnar arteries and other sites can also be used (Kumar & Geube, 2021; Saugel et al., 2020; Singh et al., 2017; Vidovich, 2018).

There are specific procedures that should be followed for placement and technique.

  • Palpation- The anatomical location of the arterial vessel should be confirmed before placement. Direct palpation of the arterial pulse assists with finding the proper location. After prepping and finding/verifying the location, the insertion may take place. The insertion angle will vary depending on the insertion, which means that some degrees may make the insertion process more difficult.
  • The Allen Test- Before the insertion of a radial arterial catheter, an Allen Test is usually performed. The test ensures that the blood flow of the artery, especially the ulnar artery, is sufficient to avoid injury. To perform this test, both radial and ulnar arteries are occluded by manual palpation for around 15 seconds until the skin on the palm blanches. The patency is considered sufficient if the blanching resolves quickly after the ulnar arterial occlusion is released (Agarwal et al., 2020).
  • Doppler Auditory Assistance- Auditory doppler devices can help determine the point of entry when accessing a needle, especially in patients with low blood pressure, and locating the pulse may be difficult (Aouad-Maroun et al., 2016).
  • Ultrasound Guidance- Ultrasound guidance increases the success rate when placing an arterial line. It reduces the number of attempts, decreasing the risk of infection. Ultrasound guidance has an even higher success rate in infants and children. Also, using ultrasound may assist in finding the appropriate catheter size; this is important in pediatric patients and is now a standard of care (Cho et al., 2021).
  • Seldinger Technique- A Seldinger Technique assists with gaining access to the arterial lumen using a guidewire. After the pulse is located, the artery is punctured with a needle. Once blood flow is detected, a guidewire is inserted into the needle hub to gain entry into the artery. Once advancement occurs, the needle can be removed. The opposite end of the guidewire is threaded into the distal end of the catheter until it is flush with the skin. The guidewire can be removed, and the tip of the guidewire should be checked for integrity, ensuring it is intact. The technique is best used when the artery runs deep into the extremity (Hsu et al., 2016).
  • Catheter Over the Needle- A peripheral venous catheter can sometimes access more superficial arteries. After the artery is located, it is punctured with the over-the-needle device. After blood flow is found, the catheter is slid over the device before the needle is removed (Kim et al., 2021).
  • Securing the Arterial Catheter- After placing the catheter, it must be secured. Securing the catheter prevents infection, dislodgement, and excessive motion that may interfere with monitoring results. Securing the catheter prevents the procedure from being repeated. Transparent adhesive dressings should be used so direct visualization is still possible. If the catheter is in the wrist, the hand should be extended slightly using a soft roll and a rigid board, allowing for fixation. The tubing should be looped around the thumb and secured to the forearm (Reynolds et al., 2018).

Contraindications

Contraindications to arterial cannulation include abnormal artery anatomy, localized infection, thrombosis, thromboangiitis obliterans, and active Raynaud's disease (Saugel et al., 2020). Note: Thromboangiitis obliterans, also known as Buerger's disease, is recurring inflammation and thrombosis of small blood vessels.

Absolute or strict contraindications for arterial cannulation include:

  • Raynaud syndrome- this is where the smaller arteries constrict in response to cold temperatures. Blood supply becomes limited, and the patient may be numb and cool in affected areas (Temprano, 2016).
  • Buerger disease
  • Absent pulse where the artery is
  • Poor perfusion of the limb 

Some relative contraindications include:

  • Infection at the site of insertion
  • Insufficient flow
  • Partial to full-thickness burns near a potential insertion site
  • Coagulopathy- a bleeding disorder that occurs when the blood is not clotting properly (Aynalem et al., 2021)
  • Atherosclerosis (moderate or severe)- buildup in the arteries causing hardening (Libby et al., 2019)
  • Vascular graft- this redirects blood flow to bypass a blockage (Hager & Burns, 2022)

Complications

Complications of radial arterial cannulation include (but are not limited to) accidental removal, hematoma, infection, ischemia caused by an embolism of thrombosis, dissection of the radial artery intima, nerve damage, occlusion, and arterial spasm (Berry, 2022; Imbrìaco et al., 2022; Nuttall et al., 2016; Scheer et al., 2002).

Post insertion, the most common complication of radial artery catheters is temporary occlusion of the artery, occurring in 1.5% to 35% of patients (Scheer et al., 2002). Temporary occlusion of the radial artery rarely causes serious complications, and permanent occlusion is rare (Scheer et al., 2002). Gleich et al. (2021) did a retrospective review of 5142 arterial cannulations (3395 radial artery cannulations), and the rate of major complications was 0.2%, and there were no complications with the radial artery cannulations.

Some common complications that can affect any insertion site include:

  • Dislodgement
  • Thrombosis
  • Pain and swelling
  • Hematoma
  • Hemorrhage
  • Embolization
  • Pseudoaneurysm
  • Infection
  • Lack of blood flow in the limb
  • Blood loss (Scheer et al., 2002)

Some complications specific to the radial artery include:

  • Thrombotic complications
  • Cerebral embolization
  • Peripheral neuropathy (Scheer et al., 2002)

Some complications specific to the femoral artery include:

  • Visceral injury of the abdomen
  • Hematoma
  • Arteriovenous fistula (Scheer et al., 2002)

Some complications specific to the brachial artery include:

  • Nerve damage
  • Embolization (Scheer et al., 2002)

There is also a high risk of thrombotic complications with the dorsalis pedis artery.

Thrombotic occlusion of the cannulated artery- this is the most common complication, regardless of the insertion site. However, the most common sites where this occurs are the radial and dorsalis pedis arteries. In fact, occlusion occurs in up to 20% of radial artery lines compared to 2% in femoral artery lines. Thrombosis is also possible when the catheter is removed. The most significant risk factor for thrombosis upon catheter removal is the size of the catheter lumen; the bigger it is, the more likely a thrombus may form. A hematoma increases the likelihood of a thrombus developing (Onal et al., 2015).

A thrombosis is more likely in female patients, those with an abnormal cardiac output, and those with a catheter in for longer than a few days.

Ischemia can occur for many reasons; many incidences can be corrected easily, but some require surgical interventions. If ischemia is diagnosed, removal of the catheter will decrease the risk of complications. However, if ischemia is still ongoing after catheter removal, the following can be considered:

  • Thrombolysis is a procedure or medication used to break up blood clots. Medication can be taken to prevent clots from forming (Ucar, 2019).
  • Anticoagulation- medications called blood thinners that prevent the formation of blood clots (Frappé et al., 2020).
  • Surgical bypass- this is done to improve blood flow through the veins; many different types of bypass can be done (Schmidt-RioValle et al., 2020).
  • Embolectomy is a minimally invasive procedure to remove a blood clot (Onal et al., 2015).

Arterial lines can contribute to blood loss. From blood draws to samples, it is not uncommon to lose up to 30 ml a day; the longer the catheter is in, the more blood loss that is seen. 

Arterial lines can be a source of infection and sepsis. The risk for infection increases after the arterial line is in for longer than 96 hours.

Arterial lines can contribute to embolization when flushing the arterial line. Risk factors that increase the potential for embolisms include:

  • Frequent flushing
  • Smaller patients
  • Injection sites, such as brachial or radial sites
  • Position air travels toward the head when the patient sits upright (Scheer et al., 2002)

Nursing Care

Radial artery cannulation is a commonly performed procedure, and there is a lot of published literature on insertion techniques and complications (Imbrìaco et al., 2022). Much less information is available about maintaining the radial arterial line, which is the nurse's primary responsibility. Despite the frequent use of radial arterial lines, little practice evidence exists in the literature about the nursing management of radial arterial lines.

The primary nursing care responsibilities for radial artery catheter care that are covered here are:

  1. Insertion site care.
  2. Blood sampling.
  • Insertion site care: Observe the insertion site and monitor the patient for signs and symptoms of infection, ischemia of the hand, and phlebitis (Plowright & Sumnall, 2022). Unlike CVADs, local and systemic infections are uncommon complications of radial artery catheters (Scheer et al., 2002). The basic dressing for a radial artery catheter is 1) a primary dressing to protect the site from contamination and 2) a securement dressing to prevent catheter movement (Gorski et al., 2021; Larsen et al., 2021). The securement dressing can be an adhesive dressing, an integrated securement device (a combination of a primary and securement dressing), a tissue adhesive, or a medical-grade glue (Gorski et al., 2021). Research studies, to date, have not shown that one type of dressing is superior in preventing infection, catheter dislodgement, occlusion, and other complications (Larsen et al., 2021; Reynolds et al., 2015).
  • Blood sampling: Arterial catheters are used for obtaining blood samples, and this must be done correctly to prevent a clot in the catheter and to ensure that there is no infusion solution in the sample (Plowright & Sumnall, 2022; Sprint Working Party et al., 2014). The recommended solution for maintaining arterial line patency is 0.9% sodium chloride (Patel et al., 2021; Sprint Working Party et al., 2014). There are documented cases of a glucose-containing solution being used. However, measured blood glucose is incorrectly high, insulin is being given, and patients are suffering significant harm and death (Patel et al., 2021; Sprint Working Party et al., 2014). Obtaining an uncontaminated blood sample from an arterial catheter can be done by 1) withdrawing and discarding a volume of blood from the system (three to five times the amount of dead space in the system, or 2) using the closed system method. These processes occur by removing the dead space volume from a distal port to the sampling port (Patel et al., 2021; Plowright & Sumnall, 2022). Patel et al. (2021) noted that removing five times the dead space volume may not remove enough glucose to measure blood glucose accurately, and the authors recommended using the closed system method. To prepare for the blood sampling procedure, hand hygiene should occur first. The equipment should be gathered, and the tray should be disinfected and decontaminated. A non-touch technique should be used to prepare equipment, such as the labels on the blood samples. Patient identification should be checked with two patient identifiers. Remember to follow the facility's policies and protocols. Verbal consent should be obtained after fully explaining the process to the patient. The patient should be in a comfortable position. The insertion site, equipment, and tubing should be checked for abnormalities. If an infusion is running, it should be clamped and paused until after the sample is collected (Leslie et al., 2013).

Blood cultures should be taken from the lumens as per orders. The rubber stopper on the blood culture bottles should be disinfected. A non-touch technique should be used, and disinfection should be done with 2% chlorhexidine and 70% isopropyl alcohol swab for a minimum of 15 seconds. It should be allowed to air dry. The needleless connector should be replaced. The catheter hub should be disinfected with 2% chlorhexidine and 70% isopropyl alcohol for 30 seconds and allowed to air dry fully. The needleless connector should be reattached and repeated for each lumen. A 20 mL syringe (for adults) and 10 mL (for pediatrics) should be connected to the needleless connector on the catheter to take blood samples. The clamp, if present, should be opened, and blood should be withdrawn. The syringe with blood should be attached to the sterile blood transfer device. A non-touch technique should be used to attach and fill the aerobic bottle; the anaerobic bottle comes next. If using a syringe, an empty one should be connected to the needleless connector. The clamp should be opened, and around 10 mL of blood should be withdrawn and discarded. If blood cultures were taken first, discarding any blood would be unnecessary (Leslie et al., 2013).

If there is a slow blood return or no blood return at all, reposition the patient and ask them to take a deep breath and hold it or cough. For CVADs that are locked with sodium chloride 0.9%, the catheter should be flushed with 10-20 mL of sodium chloride 0.9% using a pulsatile action. After, try to aspirate blood. If still no blood return, consult with providers of care (Leslie et al., 2013).

Dressing Changes

A transparent dressing should be used for both central and arterial lines. They allow for daily visualization to look for signs of infection. Transparent dressings also protect the insertion site by enabling some moisture to be drawn away. A device should be used to secure the line in place for lines that are not sutured. For lines that are oozing blood, secure the line with a gauze dressing and tape. Bulky dressings should be avoided as they delay the detection of serious bleeding. Tape or dressings should not be wrapped around the arterial line insertion site circumferentially as they can affect circulation (Reynolds et al., 2018).

Allergies should be checked before dressing changes, as some patients are allergic to specific dressing types and cleaning solutions. Contact dermatitis can occur if the chlorhexidine solution is not allowed enough time to dry. A chlorhexidine gel pad has been shown to reduce the chances of an infection within the line.

Transparent dressings should be changed every seven days or as needed. If dressings feel "boggy" or are very swollen, they should be changed. Often, they need to be changed every two days due to sweating and poor skin integrity. Gauze dressings should be changed daily and as needed. Any tape and gauze on the dressings should be changed daily. It should also be changed if it is loose or not occlusive (Reynolds et al., 2018).

Lines and insertion sites should be inspected daily. Lines should be maintained as long as no issues arise. Inserting a new line increases the risk of infection. Lines should only be changed when there is redness or infection.

Safety and Monitoring

Safety measures should be taken when caring for patients with an arterial line.

Arterial lines are effective, but they are not without risk. Infection, hemorrhage, trauma, and ischemia are possible. Swelling and impaired circulation may indicate ischemia due to occlusion from a hematoma or thrombus. Bleeding can occur if the lumen or cap is accidentally bumped. Bleeding can happen quickly and be extensive. Significant blood loss is possible if the assessment is not performed routinely. Assess for crepitus, as it can indicate infection or air. An aseptic technique should be used, primarily when the line is handled.

Flushing should be done thoroughly after blood sampling. Adequate pressure and volume should always be maintained to prevent thrombosis (Nguyen & Bora, 2022).

If the line is blocked, do not try to force it. Any clots should be aspirated first and then flushed. Flushing a clot can cause ischemia and even a heart attack.

A normal saline flush should be used every shift; accidental use of 5% dextrose can cause altered glucose levels.

Routine monitoring and assessment should occur at the start of every shift and every four hours afterward. The right solution should be confirmed, as well as adequate volume and pressure. A decreased pressure increases the risk of clotting (Nguyen & Bora, 2022).

The site should be assessed for redness, pain, swelling, or discharge. The dressing should be evaluated for bogginess and changed when warranted.

The extremity should be assessed for circulation, color, and swelling. Blanching should be observed when flushing.

Keep dressings exposed to quickly determine if bleeding or problems are present. Arterial line alarms should be kept on to detect instability or dislodgement.

Determine if there are any issues, such as position, and report concerns or issues to providers. The need for an arterial line should be reviewed daily, depending on the patient's circumstances and diagnosis. If the line is placed during an emergent situation, the need should be reassessed after the patient is stable.

Both central venous and arterial lines are necessary if the patient is unstable and extensive care is required. However, the line should be removed as soon as possible to decrease the chances of infection (Nguyen & Bora, 2022).

Removal

Removal of an arterial line requires strict adherence to a facility's policies and procedures. The removal order should be confirmed. The removal steps for an arterial line are very similar to the removal of a CVAD.

  • Hand hygiene and infection control should be followed before, during, and after the procedure. Equipment, such as an eye shield and non-sterile gloves for blood sampling, should be laid out in an accessible position.
  • Two patient identifiers should be used to confirm patient identification.
  • A vascular or provider consult may also be necessary (Kabra et al., 2015).
  • Coagulation tests should be performed to check platelets, INR, and PTT. If platelets are <50,000 or INR is >1.5, orders should be reviewed with a care provider. If the patient takes any coagulation medications, such as antiplatelet agents or anticoagulants, orders should also be reviewed with a physician. It is possible that platelets or plasma may be administered to reduce the risk of bleeding. After removal, additional site pressure may be warranted.
  • The bedside should be prepared, and the patient should be assessed. The provider should use a bedside stool to keep them in an optimal position for pressure application while reducing strain on the back. Direct pressure should be applied to stop central or arterial venous catheter bleeding. The patient may be unable to lay flat during the procedure or while pressure is applied. Assistance may be needed for positioning, pressure, or blood cultures. A sedative and analgesic may be ordered and administered if the patient is uncooperative or restless. Inadequate pressure or contamination may occur if the patient is restless due to pain or improper positioning (Kabra et al., 2015).
  • The tray at the bedside should be prepared. Hand hygiene should be performed, and the central line dressing tray should be opened. Non-sterile gowns, gloves, masks, and face shields should be worn. Sterile scissors should be used for the suture line. Chlorhexidine may be necessary for device removal. Sterile petroleum gel should be applied to the center of a gauze square. Petroleum gel creates a barrier to prevent air and possibly bacteria from entering the catheter tract. However, this gel can make hemostasis challenging; care should be taken to ensure the petroleum gel does not enter the catheter tract and bloodstream before clotting.
  • The old dressing should be removed and discarded while wearing non-sterile gloves. A swab stick may be necessary to help loosen the dressing. The site should be cleansed with chlorhexidine and allowed to dry for at least two minutes (Kabra et al., 2015).
  • The catheter should be removed. The head of the bed should be lowered, and the patient should be placed in the Trendelenburg position if possible. Dry gauze should be placed over the insertion site for ease of removal. If resistance is met, a provider of care or physician should be notified. The patient should be asked to hold their breath during the removal. The catheter should be pulled in a slow, steady motion. Direct and immediate pressure should be applied at the site for at least five minutes. Assess for bleeding and inspect the catheter to ensure it is intact. If damaged, the physician or provider of care should be notified. If warranted, the tip should be sent off for cultures (Burnham et al., 2018).
  • If the catheter is broken, direct pressure above the insertion site should be applied to stop blood flow. The patient should be positioned on their left side with their head down, and the physician or provider of care should be notified immediately. If the fractured catheter piece can be felt, additional pressure may be necessary to prevent the piece from moving.
  • Hemostasis is essential after an arterial line removal. Firm pressure should be held for a minimum of five minutes beyond the point when homeostasis has occurred. If oozing is seen, reapply pressure for another five minutes, minimum. The only way to ensure bleeding stops is direct and adequate pressure. Without hemostasis, hematomas can form, resulting in occlusion. Distal circulation should be checked.
  • After the bleeding has stopped, a transparent dressing should be applied. A transparent dressing allows the site to be seen without changing the dressing frequency, increasing the chance of bacteria and infections. Pressure dressings should not be used as they will not stop a vascular bleed and will only delay the detection of a bleed or problem. A lack of direct and adequate pressure will increase the risk of hematoma formation.
  • After catheter removal and the bleeding has stopped, limit movement of the extremity for at least one hour. The limb should be checked often for bleeding; every five minutes for the first 30 minutes, then every thirty minutes for two hours, then hourly for four hours. If bleeding reoccurs, apply pressure. The distal portion of the extremity should also be assessed for circulation at the same time.
  • Ask the patient if they are experiencing any numbness or tingling. Take blood pressure in the other arm for a while (Kabra et al., 2015).
  • The procedure should be documented, as well as follow-up assessments.

Case Study

A fifty-two-year-old male has been admitted to an ICU. He had been diagnosed with acute respiratory distress caused by COVID-19 infection, and elective intubation and mechanical ventilation were needed. In the first week of admission, the patient's pulmonary status neither deteriorated nor improved, and the providers did not feel that attempting to wean him from the ventilator was safe. On day two, a feeding tube was inserted, and enteral nutrition was begun.

On day eight of his ICU stay, the patient, who was still mechanically ventilated, developed sepsis and became hypotensive. His systolic blood pressures were consistently < 80 mm Hg, the mean arterial pressures were abnormally low, and the serum lactate, at one point, was 16 mg/dL (normal 18 mg/dL). Despite vigorous fluid resuscitation, the patient's hemodynamic state did not improve. His BUN and creatinine rose from normal values to 29 mg/dL and 1.9 mg/dl, respectively. Given these complications, the continued need for mechanical ventilation, and the likelihood that the patient might need long-term central venous access, it was decided to insert a central IV line in the external jugular vein. Infusion of norepinephrine infusion and phenylephrine were started, empiric antibiotic therapy was started, and plans were made to begin TPN. Daily chlorhexidine gluconate baths were started, the central line insertion site was covered with chlorhexidine-impregnated dressings, and a 1:1 nurse-patient ratio was used whenever possible. Within 24 hours, his blood pressure improved there was an improvement in the clinical signs of sepsis.

One day later, the phenylephrine infusion was tapered down and then discontinued. The next day the norepinephrine infusion was tapered down and discontinued. Still, the nurse noticed redness and swelling around the catheter insertion site, and the patient – who had been afebrile for 48 hours – had a temperature of 101.3°F. CLABSI was suspected (as opposed to recurrence of sepsis) because the patient was afebrile, hemodynamically stable, and perfusing well, e.g., with good urine output and good peripheral circulation. There were good alternatives for IV access, the central line was removed, and the tip was cultured. Empiric antibiotic therapy was started, two peripheral IV lines were inserted, and enteral nutrition was restarted.

Analysis: The indications for placement of a CVAD were clear; the patient needed vasopressor infusions and TPN, and there was a lack of reliable venous access. The appropriate CVAD care was given – chlorhexidine gluconate baths, chlorhexidine-impregnated dressings for the CVAD insertion, 1:1 nurse-patient ratio – but despite this, a CLABSI developed. Because the patient was hemodynamically stable and there was evidence that the sepsis was resolving, the CVAD line was removed.

Conclusion

Central venous and arterial lines are often necessary components of medical care. Central venous lines are usually indicated for administering irritants, vesicants, or vasopressors. Sometimes a central venous line is necessary for long-term access, renal replacement therapy, rapid administration of fluids, invasive hemodynamic monitoring, or the inability to obtain other IV access.

The first type of central venous access device is a PICC line. The IV catheter is inserted into a peripheral line, usually in the upper arm. PICC lines are commonly inserted for patients needing long-term access, such as chemotherapy. Though effective, complications of PICC lines include occlusion, hematomas, and infection. The next type includes tunneled and non-tunneled catheters. Though they are similar in design and function, they are used for different purposes. A tunneled catheter has both an entry site and an exit site, which are used for longer purposes. Non-tunneled catheters are for temporary use, like standard IV therapy or labs. Non-tunneled catheters do not require an incision and are usually used for two weeks or less. Totally implantable ports are also used for long-term purposes. Impregnated and coated catheters, coated with antibiotics, antimicrobials, or antimycotics, exist to decrease the accumulation and growth of bacteria and reduce catheter-related infections.

No matter which type of catheter is implanted, specific steps must be taken to complete the process properly. A CVAD with the smallest catheter and least amount of lumens should be used; these choices help to limit complications. An ultrasound should be used to insert a CVAD to reduce complications. Some common complications associated with CVAD include arrhythmias, arterial puncture, hematomas, hemothorax, lacerations, malposition, nerve injury, and pulmonary complications. Those are complications associated with insertion; there are post-insertion complications that should also be looked for. The most common type of post-insertion complication is a CLABSI. It can occur due to poor hand hygiene of the person inserting the catheter or contamination after insertion. Another complication is an air embolism, which occurs when air leaks into the bloodstream. Air embolisms can be diagnosed with an EKG, x-ray, CT scan, or, if needed, transthoracic echocardiography. Patients with air embolisms require immediate interventions such as hemodynamic support, oxygen, supportive positioning, and, worst-case scenario, CPR.

During insertion, damage is possible, which may result in catheter migration. A CVAD tip can migrate at any time after insertion. Other serious complications include a DVT, which can consist of symptoms of edema and/or pain in the chest, neck, or an extremity, erythema and/or numbness in an extremity, and difficulty moving the extremities and/or the neck. It can progress to a pulmonary embolism, evidenced by chest pain, diaphoresis, dyspnea, pleuritic pain, and tachycardia.

There are specific complications related to the catheter, including infiltration, extravasation, phlebitis, and occlusion. Both infiltration and extravasation result when fluid leaks into the surrounding tissue. Excavation occurs with vesicants and can result in increased harm, such as necrosis and tissue loss. Phlebitis results in inflammation of the vessel and can be grouped into different diagnoses, such as chemical or mechanical phlebitis. Occlusion results when something blocks the line and can also be divided into different diagnosis categories, such as chemical or mechanical occlusion.

Nursing care is pertinent, no matter if the patient has a CVAD or arterial line. Specific nursing care tasks include 1) assessment of the infusion system, 2) assessment of the insertion site, 3) dressing changes, 4) flushing and locking, and 5) observing for complications. The infusion system and the assessment site deserve routine monitoring and assessment for complications. Dressing changes should be performed as scheduled, such as every seven days, or as needed, such as when the dressing feels "boggy." Flushing, locking, and disinfecting ports require special steps and approaches.

Nursing care also means that complications should be prevented at all costs. Each complication requires different steps to prevent them. Central line infections require adequate hygiene and disinfection, and air embolisms require maintaining the integrity of the infusion system.

Central venous and arterial lines should be removed as soon as possible. Removal of catheters requires specific steps to ensure the catheter remains intact and the procedure goes smoothly. Orders should always be checked, and the facility's policies and procedures should always be followed. There are pros and cons related to the insertion and use of these devices; it depends on the patient and their situation. Regardless, safety measures must be followed.

Select one of the following methods to complete this course.

Take TestPass an exam testing your knowledge of the course material.
OR
No TestAttest that you have read and learned all the course materials.

Implicit Bias Statement

CEUFast, Inc. is committed to furthering diversity, equity, and inclusion (DEI). While reflecting on this course content, CEUFast, Inc. would like you to consider your individual perspective and question your own biases. Remember, implicit bias is a form of bias that impacts our practice as healthcare professionals. Implicit bias occurs when we have automatic prejudices, judgments, and/or a general attitude towards a person or a group of people based on associated stereotypes we have formed over time. These automatic thoughts occur without our conscious knowledge and without our intentional desire to discriminate. The concern with implicit bias is that this can impact our actions and decisions with our workplace leadership, colleagues, and even our patients. While it is our universal goal to treat everyone equally, our implicit biases can influence our interactions, assessments, communication, prioritization, and decision-making concerning patients, which can ultimately adversely impact health outcomes. It is important to keep this in mind in order to intentionally work to self-identify our own risk areas where our implicit biases might influence our behaviors. Together, we can cease perpetuating stereotypes and remind each other to remain mindful to help avoid reacting according to biases that are contrary to our conscious beliefs and values.

References

  • Abdel Al, A. Asha, W., Asha A., Chaar, M.K.A., Jarrar, A., Qawasmi, M., Salameh, H. & Alsaadi, N. (2022). Chemotherapy extravasation injuries beyond the immediate stage: A series of 15 cases treated according to a preset surgical algorithm based on time of presentation. Hand Surgery and Rehabilitation, 41(3), 391-399. Visit Source.
  • Abramson, T.M., Sanko, S., Kashani, S. & Eckstein, M. (2020). Prime the Line! A Case Report of Air Embolism from a Peripheral IV Line in the Field. Prehospital Emergency Care, 24(4), 576-579. Visit Source.
  • Agarwal, T., Agarwal, V., Agarwal, P., Thakur, S., Bobba, R., & Sharma, D. (2020). Assessment of collateral hand circulation by modified Allen's test in normal Indian subjects. Journal of clinical orthopaedics and trauma, 11(4), 626–629. Visit Source.
  • Alexander, L. (2020). Extravasation Injuries: A Trivial Injury Often Overlooked with Disastrous Consequences. World journal of plastic surgery, 9(3), 326–330. Visit Source.
  • Alotaibi, N. H., Barri, A., & Elahi, M. A. (2020). Length of Stay in Patients With Central Line- Associated Bloodstream Infection at a Tertiary Hospital in the Kingdom of Saudi Arabia. Cureus12(10), e10820. Visit Source.
  • Aouad-Maroun, M., Raphael, C. K., Sayyid, S. K., Farah, F., & Akl, E. A. (2016). Ultrasound- guided arterial cannulation for paediatrics. The Cochrane database of systematic reviews, 9(9), CD011364. Visit Source.
  • Armenteros-Yeguas, V., Gárate-Echenique, L., Tomás-López, M. A., Cristóbal-Domínguez, E., Moreno-de Gusmão, B., Miranda-Serrano, E., & Moraza-Dulanto, M. I. (2017). Prevalence of difficult venous access and associated risk factors in highly complex hospitalised patients. Journal of clinical nursing26(23-24), 4267–4275. Visit Source.
  • Ast, D., & Ast, T. (2014). Nonthrombotic complications related to central vascular access devices. Journal of infusion nursing: the official publication of the Infusion Nurses Society37(5), 349–398. Visit Source.
  • Aynalem, M., Shiferaw, E., Gelaw, Y., & Enawgaw, B. (2021). Coagulopathy and its associated factors among patients with a bleeding diathesis at the University of Gondar Specialized Referral Hospital, Northwest Ethiopia. Thrombosis journal19(1), 36. Visit Source.
  • Bakır, E., Sezer, T. A., Çavuşoğlu, H., Özkaya Parlakay, A., & Gürsel, O. (2021). Comparison of 2% Chlorhexidine Gluconate in 70% Alcohol and 10% Povidone-Iodine Used for Port Catheter Dressing Changes in Pediatric Hematology-Oncology Patients: A Prospective Observational Study. Turkish archives of pediatrics56(5), 451–457.
  • Berlana, D. (2022). Parenteral Nutrition Overview. Nutrients14(21), 4480. Visit Source.
  • Berry, C. (2022). Vascular Access. Merck Manual: Professional Version. Visit Source.
  • Bing, S., Smotherman, C., Rodriguez, R. G., Skarupa, D. J., Ra, J. H., & Crandall, M. L. (2022). PICC versus midlines: Comparison of peripherally inserted central catheters and midline catheters with respect to incidence of thromboembolic and infectious complications. American journal of surgery223(5), 983–987. Visit Source.
  • Brock, P. & Cruz-Carreras, M.T. (2020). Chapter 240: Emergency Complications of Malignancy. Judith E. Tintinalli, O. John Ma, Donald M. Yealy, Garth D. Meckler, J. Stephan Stapczynski, David M. Cline, Stephen H. Thomas (Eds). Tintinalli's Emergency Medicine: A Comprehensive Study Guide (9th ed). McGraw-Hill Education: New York, NY. Online edition.  Visit Source.
  • Buetti, N., Marschall, J., Drees, M., Fakih, M. G., Hadaway, L., Maragakis, L. L., Monsees, E., Novosad, S., O'Grady, N. P., Rupp, M. E., Wolf, J., Yokoe, D., & Mermel, L. A. (2022). Strategies to prevent central line-associated bloodstream infections in acute-care hospitals: 2022 Update. Infection control and hospital epidemiology43(5), 553–569. Visit Source.
  • Burnham, J. P., Rojek, R. P., & Kollef, M. H. (2018). Catheter removal and outcomes of multidrug-resistant central-line-associated bloodstream infection. Medicine97(42), e12782. Visit Source.
  • Caiazzo, M., Golino, L., Addeo, R., Fardello, F., Russo, G., & Imperatore, F. (2022). A delayed complication of a port-a-cath insertion via subclavian venous access: Case report of a "pinch-off syndrome". International journal of surgery case reports, 94, 107039. Visit Source.
  • Centers for Disease Control and Prevention (CDC). (2010). Checklist for Prevention of Central Line Associated Blood Stream Infections. Centers for Disease Control and Prevention. Visit Source.
  • Chandrashekarappa, K., Hang, D., & Pagel, P. S. (2018). An Alternative Technique for Radial Arterial Catheterization. Journal of cardiothoracic and vascular anesthesia32(4), e88– e89. Visit Source.
  • Chinn, M., & Colella, M. R. (2017). Prehospital Dextrose Extravasation Causing Forearm Compartment Syndrome: A Case Report. Prehospital emergency care21(1), 79–82. Visit Source.
  • Cho, K.S., Ahn, H.C., Lee, J.H., Lim, S.Y., Lee, H.J. & Park, H.K. (2019). Extravasation wound care in the neonatal intensive care unit. Journal of Wound Management Research,15(1),17–22. Visit Source.
  • Cho, S. A., Jang, Y. E., Ji, S. H., Kim, E. H., Lee, J. H., Kim, H. S., & Kim, J. T. (2021). Ultrasound-guided arterial catheterization. Anesthesia and pain medicine16(2), 119– 132. Visit Source.
  • Chopra, V., O'Malley, M., Horowitz, J., Zhang, Q., McLaughlin, E., Saint, S., Bernstein, S. J., & Flanders, S. (2022). Improving peripherally inserted central catheter appropriateness and reducing device-related complications: a quasiexperimental study in 52 Michigan hospitals. BMJ quality & safety, 31(1), 23–30. Visit Source.
  • Chuah, J. S., Wong, W. L., Bakin, S., Lim, R. Z. M., Lee, E. P., & Tan, J. H. (2021). Pinch-off syndrome from a chemoport catheter successfully managed with endovascular retrieval. Annals of medicine and surgery (2012), 65, 102294. Visit Source.
  • Citla Sridhar, D., Abou-Ismail, M. Y., & Ahuja, S. P. (2020). Central venous catheter-related thrombosis in children and adults. Thrombosis research, 187, 103–112. Visit Source.
  • Clark, E., Kappel, J., MacRae, J., Dipchand, C., Hiremath, S., Kiaii, M., Lok, C., Moist, L., Oliver, M., Miller, L. M., & Canadian Society of Nephrology Vascular Access Work Group (2016). Practical Aspects of Nontunneled and Tunneled Hemodialysis Catheters. Canadian journal of kidney health and disease, 3, 2054358116669128. Visit Source.
  • David, V., Christou, N., Etienne, P., Almeida, M., Roux, A., Taibi, A., & Mathonnet, M. (2020). Extravasation of Noncytotoxic Drugs. The Annals of pharmacotherapy54(8), 804–814. Visit Source.
  • De Backer, D., & Vincent, J. L. (2018). Should we measure the central venous pressure to guide fluid management? Ten answers to 10 questions. Critical care (London, England)22(1), 43. Visit Source.
  • Duwadi, S., Zhao, Q., & Budal, B. S. (2018). Peripherally inserted central catheters in critically ill patients - complications and its prevention: A review. International journal of nursing sciences6(1), 99–105. Visit Source.
  • Ferroni, A., Gaudin, F., Guiffant, G., Flaud, P., Durussel, J. J., Descamps, P., Berche, P., Nassif, X., & Merckx, J. (2014). Pulsative flushing as a strategy to prevent bacterial colonization of vascular access devices. Medical devices (Auckland, N.Z.), 7, 379–383. Visit Source.
  • Fisher, M., Golestaneh, L., Allon, M., Abreo, K., & Mokrzycki, M. H. (2020). Prevention of Bloodstream Infections in Patients Undergoing Hemodialysis. Clinical journal of the American Society of Nephrology: CJASN15(1), 132–151.
  • Flick, A.I. & Winters, R. (2022). Vascular Tunneled Central Catheter Access. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. Visit Source.
  • Fohlen, A., Briant, A. R., Dutheil, J. J., Le Pennec, V., Pelage, J. P., & Parienti, J. J. (2022). Complications of peripherally inserted central catheters in adult hospitalized patients and outpatients in the KTFIXPICC study: A randomized controlled trial evaluating a fixation device KT FIX Plussystem. American journal of infection control, 50(8), 916–921. Visit Source.
  • Foti, L., Michard, F., Villa, G., Ricci, Z., & Romagnoli, S. (2022). The impact of arterial pressure waveform underdamping and resonance filters on cardiac output measurements with pulse wave analysis. British journal of anaesthesia129(1), e6–e8. Visit Source.
  • Frappé, P., Cogneau, J., Gaboreau, Y., Abenhaïm, N., Bayen, M., Guichard, C., Jacquet, J. P., Lacoin, F., Liébart, S., Bertoletti, L., Bosson, J. L., & CACAO study investigators (2020). Anticoagulants' Safety and Effectiveness in General Practice: A Nationwide Prospective Cohort Study. Annals of family medicine18(2), 131–138. Visit Source.
  • Gallant, P., & Schultz, A. A. (2006). Evaluation of a visual infusion phlebitis scale for determining appropriate discontinuation of peripheral intravenous catheters. Journal of infusion nursing : the official publication of the Infusion Nurses Society29(6), 338–345. Visit Source.
  • Gelb, A. W., Morriss, W. W., Johnson, W., Merry, A. F., Abayadeera, A., Belîi, N., Brull, S. J., Chibana, A., Evans, F., Goddia, C., Haylock-Loor, C., Khan, F., Leal, S., Lin, N., Merchant, R., Newton, M. W., Rowles, J. S., Sanusi, A., Wilson, I., Velazquez Berumen, A., … International Standards for a Safe Practice of Anesthesia Workgroup. (2018). World Health Organization-World Federation of Societies of Anaesthesiologists (WHO- WFSA) International Standards for a Safe Practice of Anesthesia. Anesthesia and analgesia, 126(6), 2047–2055. Visit Source.
  • Gleich, S. J., Wong, A. V., Handlogten, K. S., Thum, D. E., & Nemergut, M. E. (2021). Major Short-term Complications of Arterial Cannulation for Monitoring in Children. Anesthesiology134(1), 26–34. Visit Source.
  • Goossens, G. A. (2015). Flushing and Locking of Venous Catheters: Available Evidence and Evidence Deficit. Nursing research and practice, 2015, 985686. Visit Source.
  • Gorski, L. A., Hadaway, L., Hagle, M. E., Broadhurst, D., Clare, S., Kleidon, T., Meyer, B. M., Nickel, B., Rowley, S., Sharpe, E., & Alexander, M. (2021). Infusion Therapy Standards of Practice, 8th Edition. Journal of infusion nursing: the official publication of the Infusion Nurses Society44(1S Suppl 1), S1–S224. Visit Source.
  • Grau, D., Clarivet, B., Lotthé, A., Bommart, S., & Parer, S. (2017). Complications with peripherally inserted central catheters (PICCs) used in hospitalized patients and outpatients: a prospective cohort study. Antimicrobial resistance and infection control, 6, 18. Visit Source.
  • Haddadin, Y., Annamaraju, P., & Regunath, H. (2022). Central Line Associated Blood Stream Infections. In StatPearls. StatPearls Publishing.
  • Hager, H.H., & Burns, B. (2022). Artery Cannulation. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. Visit Source.
  • Hanrahan, N.P., Letourneau, L. & Batty, R. (2022). Nurse Management of Radial Arterial Lines: Quality & Safety. American Journal of Nursing Research, 10(7), 7-15.
  • Helder, O. K., van Rosmalen, J., van Dalen, A., Schafthuizen, L., Vos, M. C., Flint, R. B., Wildschut, E., Kornelisse, R. F., & Ista, E. (2020). Effect of the use of an antiseptic barrier cap on the rates of central line-associated bloodstream infections in neonatal and pediatric intensive care. American journal of infection control, 48(10), 1171–1178. Visit Source.
  • Heng, S. Y., Yap, R. T., Tie, J., & McGrouther, D. A. (2020). Peripheral Vein Thrombophlebitis in the Upper Extremity: A Systematic Review of a Frequent and Important Problem. The American journal of medicine, 133(4), 473–484.e3. Visit Source.
  • Higgins, M., Zhang, L., Ford, R., Brownlie, J., Kleidon, T., Rickard, C. M., & Ullman, A. (2021). The microbial biofilm composition on peripherally inserted central catheters: A comparison of polyurethane and hydrophobic catheters collected from paediatric patients. The journal of vascular access22(3), 388–393. Visit Source.
  • Hill, B., & Smith, C. (2021). Central venous pressure monitoring in critical care settings. British journal of nursing (Mark Allen Publishing)30(4), 230–236. Visit Source.
  • Hsu, C. C., Kwan, G. N., Evans-Barns, H., Rophael, J. A., & van Driel, M. L. (2016). Venous cutdown versus the Seldinger technique for placement of totally implantable venous access ports. The Cochrane database of systematic reviews2016(8), CD008942. Visit Source.
  • Huerta, L. E., Nelson, G. E., Stewart, T. G., & Rice, T. W. (2018). Factors associated with recurrence and mortality in central line-associated bloodstream infections: a retrospective cohort study. Critical care (London, England)22(1), 266. Visit Source.
  • Imbrìaco, G., Monesi, A., & Spencer, T. R. (2022). Preventing radial arterial catheter failure in critical care - Factoring updated clinical strategies and techniques. Anaesthesia, critical care & pain medicine41(4), 101096. Visit Source.
  • Kabra, A., Purohit, A., & Parashar, V. (2015). Peripherally inserted central venous catheter line removal leading to brachial vein stripping- Need for more caution. Indian journal of anaesthesia59(12), 814–815. Visit Source.
  • Karius, D. L., & Colvin, C. M. (2021). Managing Chemotherapy Extravasation Across Transitions of Care: A Clinical Nurse Specialist Initiative. Journal of infusion nursing : the official publication of the Infusion Nurses Society44(1), 14–20. Visit Source.
  • Kaufmann, T., Cox, E. G. M., Wiersema, R., Hiemstra, B., Eck, R. J., Koster, G., Scheeren, T. W. L., Keus, F., Saugel, B., van der Horst, I. C. C., & SICS Study Group. (2020). Non- invasive oscillometric versus invasive arterial blood pressure measurements in critically ill patients: A post hoc analysis of a prospective observational study. Journal of critical care57, 118–123. Visit Source.
  • Khaliq, M. F., Shoaib, M., Tariq, S. M., & Khan, M. T. (2018). Cerebral air embolism from a Central Venous Catheter: A timely reminder of the importance of rapid diagnosis. BMJ case reports, 2018, bcr2018225120. Visit Source.
  • Kim, H. Y., Ahn, J. S., Park, S., Choi, E. J., Ri, H. S., Yoon, J. U., & Byeon, G. J. (2021). Comparison of catheter-over-needle and catheter-through-needle methods in ultrasound- guided continuous femoral nerve block: A prospective, randomized controlled trial. Medicine100(26), e26519. Visit Source.
  • Kumar, N., & Geube, M. (2021). Commentary: Is it time to revisit the arterial pressure monitoring site for cardiac surgery? JTCVS open, 8, 465–466. Visit Source.
  • Lai, N. M., Chaiyakunapruk, N., Lai, N. A., O'Riordan, E., Pau, W. S., & Saint, S. (2016a). Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults. The Cochrane database of systematic reviews3(3), CD007878. Visit Source.
  • Lai, N. M., Lai, N. A., O'Riordan, E., Chaiyakunapruk, N., Taylor, J. E., & Tan, K. (2016b). Skin antisepsis for reducing central venous catheter-related infections. The Cochrane database of systematic reviews7(7), CD010140. Visit Source.
  • Lakhal, K., Ehrmann, S., & Boulain, T. (2018). Noninvasive BP Monitoring in the Critically Ill: Time to Abandon the Arterial Catheter? Chest153(4), 1023–1039. Visit Source.
  • Lakshmi, H. N., Sharma, M., Jain, A., Puj, K., Jayaprakash, D., & Pandya, S. (2022). Chemoport Fracture due to Catheter Pinch Off Syndrome: A Rare Complication of Subclavian Vein Approach Revisited. Indian journal of surgical oncology13(2), 343–347. Visit Source.
  • Lam, S., Liu, H., Jian, Z., Settels, J., & Bohringer, C. (2021). Intraoperative Invasive Blood Pressure Monitoring and the Potential Pitfalls of Invasively Measured Systolic Blood Pressure. Cureus13(8), e17610. Visit Source.
  • Larsen, E. N., Corley, A., Mitchell, M., Lye, I., Powell, M., Tom, S., Mihala, G., Ullman, A. J., Gibson, V., Marsh, N., Kleidon, T. M., Rapchuk, I. L., & Rickard, C. M. (2021). A pilot randomised controlled trial of dressing and securement methods to prevent arterial catheter failure in intensive care. Australian critical care: official journal of the Confederation of Australian Critical Care Nurses, 34(1), 38–46. Visit Source.
  • Lawson, S. L., Brady, W., & Mahmoud, A. (2013). Identification of highly concentrated dextrose solution (50% dextrose) extravasation and treatment--a clinical report. The American journal of emergency medicine31(5), 886.e3–886.e886005. Visit Source.
  • Leslie, R. A., Gouldson, S., Habib, N., Harris, N., Murray, H., Wells, V., & Cook, T. M. (2013). Management of arterial lines and blood sampling in intensive care: a threat to patient safety. Anaesthesia68(11), 1114–1119. Visit Source.
  • Lewis, T., Merchan, C., Altshuler, D., & Papadopoulos, J. (2019). Safety of the Peripheral Administration of Vasopressor Agents. Journal of intensive care medicine34(1), 26–33. Visit Source.
  • Li, S., & Lu, H. (2022). Functions of Heparin Sodium Injection in the Prevention of Peripherally Inserted Central Catheter-Related Venous Thrombosis in NSCLC Patients during Postoperative Chemotherapy. Computational and mathematical methods in medicine, 2022, 1239058. Visit Source.
  • Libby, P., Buring, J. E., Badimon, L., Hansson, G. K., Deanfield, J., Bittencourt, M. S., Tokgözoğlu, L., & Lewis, E. F. (2019). Atherosclerosis. Nature reviews. Disease primers5(1), 56. Visit Source.
  • Lin, M. R., Chang, P. J., Hsu, P. C., Lin, C. S., Chiu, C. H., & Chen, C. J. (2022). Comparison of Efficacy of 2% Chlorhexidine Gluconate-Alcohol and 10% Povidone-Iodine-Alcohol against Catheter-Related Bloodstream Infections and Bacterial Colonization at Central Venous Catheter Insertion Sites: A Prospective, Single-Center, Open-Label, Crossover Study. Journal of clinical medicine11(8), 2242. Visit Source.
  • Lockwood, J., & Desai, N. (2019). Central venous access. British journal of hospital medicine (London, England : 2005), 80(8), C114–C119. Visit Source.
  • López-Briz, E., Ruiz Garcia, V., Cabello, J. B., Bort-Martí, S., Carbonell Sanchis, R., & Burls, A. (2018). Heparin versus 0.9% sodium chloride locking for prevention of occlusion in central venous catheters in adults. The Cochrane database of systematic reviews, 7(7), CD008462. Visit Source.
  • Lu, H., Yang, Q., Tian, B., Lyu, Y., Zheng, X., & Xin, X. (2022). A meta-analysis of the comparison of phlebitis between midline catheters and peripherally inserted central catheters in infusion therapy. International journal of nursing practice, 28(2), e12976. Visit Source.
  • Lutwick, L., Al-Maani, A. S., Mehtar, S., Memish, Z., Rosenthal, V. D., Dramowski, A., Lui, G., Osman, T., Bulabula, A., & Bearman, G. (2019). Managing and preventing vascular catheter infections: A position paper of the international society for infectious diseases. International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases, 84, 22–29. Visit Source.
  • Machat, S., Eisenhuber, E., Pfarl, G., Stübler, J., Koelblinger, C., Zacherl, J., & Schima, W. (2019). Complications of central venous port systems: a pictorial review. Insights into imaging10(1), 86. Visit Source.
  • Manrique-Rodríguez, S., Heras-Hidalgo, I., Pernia-López, M. S., Herranz-Alonso, A., Del Río Pisabarro, M. C., Suárez-Mier, M. B., Cubero-Pérez, M. A., Viera-Rodríguez, V., Cortés- Rey, N., Lafuente-Cabrero, E., Martínez-Ortega, M. C., Bermejo-López, E., Díez-Sáenz, C., López-Sánchez, P., Gaspar-Carreño, M. L., Achau-Muñoz, R., Márquez-Peiró, J. F., Valera-Rubio, M., Domingo-Chiva, E., Aquerreta-González, I., … Sanjurjo-Sáez, M. (2021). Standardization and Chemical Characterization of Intravenous Therapy in Adult Patients: A Step Further in Medication Safety. Drugs in R&D, 21(1), 39–64. Visit Source.
  • Martinez, O., & Puller, J. (2021). Mediastinitis Secondary to Peripherally Inserted Central Catheter Migration and Perforation after Minor Trauma: A Case Report. Clinical practice and cases in emergency medicine, 5(1), 70–74. Visit Source.
  • Masood, L., Yasir, S., Rana, A. I., Ali, K. M., Shah, M., & Riaz, N. (2022). An audit of contrast extravasation in patients undergoing contrast enhanced CTs at radiology department in a tertiary care hospital in Pakistan. JPMA. The Journal of the Pakistan Medical Association72(8), 1603–1607. Visit Source.
  • McCarthy, C. J., Behravesh, S., Naidu, S. G., & Oklu, R. (2017). Air Embolism: Diagnosis, Clinical Management and Outcomes. Diagnostics (Basel, Switzerland)7(1), 5. Visit Source.
  • McConville, J.F. & Patel, B.K. (2015). Chapter 27: Intravascular Devices in the ICU. In: Jesse B. Hall, Gregory A. Schmidt, John P. Kress (Eds.). Principles of Critical Care (4th ed.). McGraw-Hill Education: New York, NY. Visit Source.
  • Meidert, A. S., Dolch, M. E., Mühlbauer, K., Zwissler, B., Klein, M., Briegel, J., & Czerner, S. (2021). Oscillometric versus invasive blood pressure measurement in patients with shock: a prospective observational study in the emergency department. Journal of clinical monitoring and computing35(2), 387–393. Visit Source.
  • Mendu, M. L., May, M. F., Kaze, A. D., Graham, D. A., Cui, S., Chen, M. E., Shin, N., Aizer, A. A., & Waikar, S. S. (2017). Non-tunneled versus tunneled dialysis catheters for acute kidney injury requiring renal replacement therapy: a prospective cohort study. BMC nephrology18(1), 351. Visit Source.
  • Mercolini, F., Di Leo, V., Bordin, G., Melotti, R., Sperotto, F., Pettenazzo, A., Amigoni, A., & Tosoni, A. (2021). Central Venous Pressure Estimation by Ultrasound Measurement of Inferior Vena Cava and Aorta Diameters in Pediatric Critical Patients: An Observational Study. Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 22(1), e1–e9. Visit Source.
  • Naik, V. M., Cheruku, D. R., Swathi, U., & Rayani, B. K. (2022). Femoral peripherally inserted central catheter in superior vena cava syndrome - Challenges of tunnelling. Indian journal of anaesthesia66(5), 388–389. Visit Source.
  • Nguyen, Y., & Bora, V. (2022). Arterial Pressure Monitoring. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. Visit Source.
  • Niemann, B., Dudas, L., Gray, D., Pettit, A., Wilson, A., & Bardes, J. M. (2022). Biofilm Formation on Central Venous Catheters: A Pilot Study. The Journal of surgical research, 280, 123–128. Visit Source.
  • Nuttall, G., Burckhardt, J., Hadley, A., Kane, S., Kor, D., Marienau, M. S., Schroeder, D. R., Handlogten, K., Wilson, G., & Oliver, W. C. (2016). Surgical and Patient Risk Factors f or Severe Arterial Line Complications in Adults. Anesthesiology, 124(3), 590–597. Visit Source.
  • Onal, O., Salman, E., Yetisir, F., & Kilic, M. (2015). Hand ischaemia after radial artery cannulation. BMJ case reports, 2015, bcr2015211145. Visit Source.
  • Ornowska, M., Wong, H., Ouyang, Y., Mitra, A., White, A., Willems, S., Wittmann, J., & Reynolds, S. (2022). Control of Line Complications with KiteLock (CLiCK) in the critical care unit: study protocol for a multi-center, cluster-randomized, double-blinded, crossover trial investigating the effect of a novel locking fluid on central line complications in the critical care population. Trials23(1), 719. Visit Source.
  • Parenti, N., Bastiani, L., Tripolino, C., & Bacchilega, I. (2022). Ultrasound imaging and central venous pressure in spontaneously breathing patients: a comparison of ultrasound-based measures of internal jugular vein and inferior vena cava. Ultrasound imaging and central venous pressure in spontaneously breathing patients: a comparison of ultrasound-based measures of internal jugular vein and inferior vena cava. Anaesthesiology intensive therapy54(2), 150–155. Visit Source.
  • Patel, V., Skorupska, N., Hodges, E. J., Blunt, M. C., Young, P. J., & Mariyaselvam, M. Z. (2021). The glucose error in arterial sampling: assessing staff awareness and the effect of sampling technique. Journal of the Intensive Care Society22(4), 319–327. Visit Source.
  • Plowright, C. & Sumnall, R. (2022). Essential critical care skills 3: arterial line care. Nursing Times [online]; 118: 1, 24-26. Visit Source.
  • Puri, A., Dai, H., Giri, M., Wu, C., Huang, H., & Zhao, Q. (2022). The incidence and risk of venous thromboembolism associated with peripherally inserted central venous catheters in hospitalized patients: A systematic review and meta-analysis. Frontiers in cardiovascular medicine, 9, 917572. Visit Source.
  • Ramakrishnan, D. (2016). Using Korotkoff Sounds to Detect the Degree of Vascular Compliance in Different Age Groups. Journal of clinical and diagnostic research: JCDR, 10(2), CC04–CC7. Visit Source.
  • Reynolds, H., Taraporewalla, K., Tower, M., Mihala, G., Tuffaha, H. W., Fraser, J. F., & Rickard, C. M. (2015). Novel technologies can provide effective dressing and securement for peripheral arterial catheters: A pilot randomised controlled trial in the operating theatre and the intensive care unit. Australian critical care : official journal of the Confederation of Australian Critical Care Nurses28(3), 140–148. Visit Source.
  • Reynolds, H., Ullman, A. J., Culwick, M. D., Mihala, G., Alexandrou, E., Schults, J. A., & Rickard, C. M. (2018). Dressings and securement devices to prevent complications for peripheral arterial catheters. The Cochrane Database of Systematic Reviews2018(5), CD013023. Visit Source.
  • Reynolds, S. S., Woltz, P., Keating, E., Neff, J., Elliott, J., Hatch, D., Yang, Q., & Granger, B. B. (2021). Results of the CHlorhexidine Gluconate Bathing implementation intervention to improve evidence-based nursing practices for prevention of central line associated bloodstream infections Study (CHanGing BathS): a stepped wedge cluster randomized trial. Implementation science: IS, 16(1), 45. Visit Source.
  • Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., Rochwerg, B., Rubenfeld, G. D., Angus, D. C., Annane, D., Beale, R. J., Bellinghan, G. J., Bernard, G. R., Chiche, J. D., Coopersmith, C., De Backer, D. P., … Dellinger, R. P. (2017). Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive care medicine43(3), 304–377. Visit Source.
  • Rickard, C. M., Flynn, J., Larsen, E., Mihala, G., Playford, E. G., Shaw, J., Keogh, S., Ullman, A., Zhang, L., Gavin, N., Kleidon, T., Chopra, V., McCarthy, A. L., Rocha, P. K., & Marsh, N. (2021). Needleless connector decontamination for prevention of central venous access device infection: A pilot randomized controlled trial. American journal of infection control49(2), 269–273. Visit Source.
  • Sakuraya, M., Okano, H., Yoshihiro, S., Niida, S., & Kimura, K. (2022). Insertion site of central venous catheter among hospitalized adult patients: A systematic review and network meta-analysis. Frontiers in medicine, 9, 960135.
  • Santos, F. K. Y., Flumignan, R. L. G., Areias, L. L., Sarpe, A. K. P., Amaral, F. C. F., Ávila, R. B., Vasconcelos, V. T., Guedes Neto, H. J., Amorim, J. E., & Nakano, L. C. U. (2020). Peripherally inserted central catheter versus central venous catheter for intravenous access: A protocol for systematic review and meta-analysis. Medicine99(30), e20352. Visit Source.
  • Saugel, B., Kouz, K., Meidert, A. S., Schulte-Uentrop, L., & Romagnoli, S. (2020). How to measure blood pressure using an arterial catheter: a systematic 5-step approach. Critical care (London, England), 24(1), 172. Visit Source.
  • Scheer, B., Perel, A., & Pfeiffer, U. J. (2002). Clinical review: complications and risk factors of peripheral arterial catheters used for haemodynamic monitoring in anaesthesia and intensive care medicine. Critical care (London, England), 6(3), 199–204. Visit Source.
  • Scheier, T., Kuster, S. P., Dunic, M., Falk, C., Sax, H., & Schreiber, P. W. (2021). Does continuity in nursing staff matter? A pilot study on correlation of central line-associated bloodstream infections and employee turnover. Antimicrobial resistance and infection control10(1), 90. Visit Source.
  • Schmidt-RioValle, J., Abu Ejheisheh, M., Membrive-Jiménez, M. J., Suleiman-Martos, N., Albendín-García, L., Correa-Rodríguez, M., & Gómez-Urquiza, J. L. (2020). Quality of Life After Coronary Artery Bypass Surgery: A Systematic Review and Meta- Analysis. International journal of environmental research and public health17(22), 8439. Visit Source.
  • See, K. C. (2022). Management of circulatory shock and hypotension. Singapore medical journal, 63(5), 239–244. Visit Source.
  • Selby, L. M., Rupp, M. E., & Cawcutt, K. A. (2021). Prevention of Central-Line Associated Bloodstream Infections: 2021 Update. Infectious disease clinics of North America, 35(4), 841–856. Visit Source.
  • Shah, P. & Louis, M.S. (2022). Physiology, Central Venous Pressure. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. Visit Source.
  • Sharp, R., Cummings, M., Fielder, A., Mikocka-Walus, A., Grech, C., & Esterman, A. (2015). The catheter to vein ratio and rates of symptomatic venous thromboembolism in patients with a peripherally inserted central catheter (PICC): a prospective cohort study. International journal of nursing studies52(3), 677–685. Visit Source.
  • Shrestha, N., Acharya, U., Shrestha, P. S., Acharya, S. P., Karki, B., & Dhakal, S. S. (2020). Topical nitroglycerin for management of peripheral extravasation of vasopressors: a case report. Oxford medical case reports, 2020(8), omaa066. Visit Source.
  • Singh, A., Bahadorani, B., Wakefield, B. J., Makarova, N., Kumar, P. A., Tong, M. Z., Sessler, D. I., & Duncan, A. E. (2017). Brachial Arterial Pressure Monitoring during Cardiac Surgery Rarely Causes Complications. Anesthesiology126(6), 1065–1076. Visit Source.
  • Smith, S. N., Moureau, N., Vaughn, V. M., Boldenow, T., Kaatz, S., Grant, P. J., Bernstein, S. J., Flanders, S. A., & Chopra, V. (2017). Patterns and Predictors of Peripherally Inserted Central Catheter Occlusion: The 3P-O Study. Journal of vascular and interventional radiology: JVIR, 28(5), 749–756.e2. Visit Source.
  • Sohail, M. A., Vachharajani, T. J., & Anvari, E. (2021). Central Venous Catheters for Hemodialysis-the Myth and the Evidence. Kidney international reports6(12), 2958– 2968. Visit Source.
  • Somand, D.M. & Ward, K.R. (2020). Chapter 13: Approach to traumatic shock. In: Judith E. Tintinalli, O. John Ma, Donald M. Yealy, Garth D. Meckler, J. Stephan Stapczynski, David M. Cline & Stephen H. Thomas (Eds.) Tintinalli's Emergency Medicine: A Comprehensive Study Guide (8th ed.). McGraw-Hill Education: New York, NY. Online edition. Visit Source.
  • Sprint Working Party, Woodcock, T. E., Cook, T. M., Gupta, K. J., & Hartle, A. (2014). Arterial line blood sampling: preventing hypoglycaemic brain injury 2014: the Association of Anaesthetists of Great Britain and Ireland. Anaesthesia, 69(4), 380–385. Visit Source.
  • Stevens, S. M., Woller, S. C., Kreuziger, L. B., Bounameaux, H., Doerschug, K., Geersing, G. J., Huisman, M. V., Kearon, C., King, C. S., Knighton, A. J., Lake, E., Murin, S., Vintch, J. R. E., Wells, P. S., & Moores, L. K. (2021). Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report. Chest, 160(6), e545– e608. Visit Source.
  • Swaminathan, L., Flanders, S., Horowitz, J., Zhang, Q., O'Malley, M., & Chopra, V. (2022). Safety and Outcomes of Midline Catheters vs Peripherally Inserted Central Catheters for Patients With Short-term Indications: A Multicenter Study. JAMA internal medicine182(1), 50–58. Visit Source.
  • Tejada, S., Leal-Dos-Santos, M., Peña-López, Y., Blot, S., Alp, E., & Rello, J. (2022). Antiseptic barrier caps in central line-associated bloodstream infections: A systematic review and meta-analysis. European journal of internal medicine, 99, 70–81. Visit Source.
  • Temprano, K. K. (2016). A Review of Raynaud's Disease. Missouri medicine, 113(2), 123–126.
  • Tian, D. H., Smyth, C., Keijzers, G., Macdonald, S. P., Peake, S., Udy, A., & Delaney, A. (2020). Safety of peripheral administration of vasopressor medications: A systematic review. Emergency medicine Australasia : EMA, 32(2), 220–227. Visit Source.
  • Tjong, F. V. Y., de Ruijter, U. W., Beurskens, N. E. G., & Knops, R. E. (2019). A comprehensive scoping review on transvenous temporary pacing therapy. Netherlands heart journal: monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 27(10), 462–473. Visit Source.
  • Tolson, O. W. (2022). Should central venous pressure be used to guide critical care management? British journal of hospital medicine(London, England : 2005), 83(10), 1– 3. Visit Source.
  • Ucar, E. Y. (2019). Update on Thrombolytic Therapy in Acute Pulmonary Thromboembolism. The Eurasian journal of medicine, 51(2), 186–190. Visit Source.
  • Vaughn, V. M., O'Malley, M., Flanders, S. A., Gandhi, T. N., Petty, L. A., Malani, A. N., Weinmann, A., Horowitz, J. K., & Chopra, V. (2020). Association of Infectious Disease Physician Approval of Peripherally Inserted Central Catheter With Appropriateness and Complications. JAMA network open, 3(10), e2017659. Visit Source.
  • Vidovich, M. I. (2018). Ulnar Artery Catheterization: Is This Our Second Access Site or Is It Still Femoral? Current cardiology reports20(10), 91. Visit Source.
  • Voor In 't Holt, A. F., Helder, O. K., Vos, M. C., Schafthuizen, L., Sülz, S., van den Hoogen, A., & Ista, E. (2017). Antiseptic barrier cap effective in reducing central line-associated bloodstream infections: A systematic review and meta-analysis. International journal of nursing studies, 69, 34–40. Visit Source.
  • Wang, M., Hao, H., Leeper, N. J., Zhu, L., & Early Career Committee (2018). Thrombotic Regulation From the Endothelial Cell Perspectives. Arteriosclerosis, thrombosis, and vascular biology38(6), e90–e95. Visit Source.
  • Webster, J., McGrail, M., Marsh, N., Wallis, M. C., Ray-Barruel, G., & Rickard, C. M. (2015). Postinfusion Phlebitis: Incidence and Risk Factors. Nursing research and practice, 2015, 691934. Visit Source.
  • White, D., Woller, S. C., Stevens, S. M., Collingridge, D. S., Chopra, V., & Fontaine, G. V. (2018). Comparative thrombosis risk of vascular access devices among critically ill medical patients. Thrombosis research, 172, 54–60. Visit Source.
  • Woller, S. C., Stevens, S. M., & Evans, R. S. (2016). The Michigan Appropriateness Guide for Intravenous Catheters (MAGIC) initiative: A summary and review of peripherally inserted central catheter and venous catheter appropriate use. Journal of hospital medicine11(4), 306–310. Visit Source.
  • Woods, C., Hughes, P., Wood, M., Ryan, S., & Powers, J. (2022). Improved Patient Safety and Quality Outcomes With Amiodarone Infusions. Journal of nursing care quality37(2), 130–134. Visit Source.
  • You, T.H. & Oliver, M.J. (2022). Central venous catheters for acute and chronic hemodialysis access and their management. UpToDate. Visit Source.
  • Yuen, H. L. A., Zhao, J., Tran, H., & Chunilal, S. D. (2022). Development of a risk score to predict peripherally inserted central catheter thrombosis in active cancer. Internal medicine journal52(10), 1733–1740. Visit Source.
  • Zhou, Y., Lan, Y., Zhang, Q., Song, J., He, J., Peng, N., Peng, X., & Yang, X. (2022). Totally implantable venous access ports: A systematic review and meta-analysis comparing subclavian and internal jugular vein punctures. Phlebology37(4), 279–288. Visit Source.